Current Size: 100%

Publications

Publications of the LBI for Cardiovascular Research 2020

Only original papers or reviews on which either a PI or one of his/her co-workers associated with the respective project appear as first, last or corresponding author (highlighted in bold) are considered publications of the institute.

Publications ASC:

  • Aigner P, Schweiger M, Fraser K, Choi Y, Lemme F, Cesarovic N, Kertzscher U, Schima H, Hübler M,
  • Grabska J, Schlöglhofer T, Gross C, Maw M, Dimitrov K, Wiedemann D, Zimpfer D, Schima H, Moscato F. Early detection of pump Tthrombosis in patients with left ventricular assist device. ASAIO J. 2020;66:348-354.
  • Granegger M. Ventricular flow field visualization during mechanical circulatory support in the assisted isolated beating heart. Ann Biomed Eng. 2020;48:794-804.
  • Gross C, Fresiello L, Schlöglhofer T, Dimitrov K, Marko C, Maw M, Meyns B, Wiedemann D, Zimpfer D, Schima H, Moscato F. Hemodynamic exercise responses with a continuous-flow left ventricular assist device: Comparison of patients' response and cardiorespiratory simulations. PLoS One. 2020;15:e0229688.
  • Gross C, Moscato F, Schlöglhofer T, Maw M, Meyns B, Marko C, Wiedemann D, Zimpfer D, Schima H, Fresiello L. LVAD speed increase during exercise, which patients would benefit the most? A simulation study. Artif Organs. 2020;44:239-247.
  • Gross C, Schima H, Schlöglhofer T, Dimitrov K, Maw M, Riebandt J, Wiedemann D, Zimpfer D, Moscato F. Continuous LVAD monitoring reveals high suction rates in clinically stable outpatients. Artif Organs. 2020;44:E251-E262.
  • Kertzscher U, Lommel M, Gabel G, Ładyżyński P, Schima H. In Memoriam: Klaus Affeld. Int J Artif Organs. 2020;43:292-293.
  • Stoiber M, Grasl C, Frieberger K, Moscato F, Bergmeister H, Schima H. Impact of the testing protocol on the mechanical characterization of small diameter electrospun vascular grafts. J Mech Behav Biomed Mater. 2020;104:103652.
  • Stoiber M, Aigner P, Grasl C, Röhrich M, Moscato F, Schima H. Dynamic measurement of centering forces on transvalvular cannulas. Artif Organs. 2020;44:E150-E160.

 

Publications INFO:

  • Demyanets S, Kaun C, Kaider A, Speidl W, Prager M, Oravec S, Hohensinner P, Wojta J, Rega-Kaun G. The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery. Cardiovasc Diabetol. 2020;19:26.
  • Hammer A, Sulzgruber P, Koller L, Kazem N, Hofer F, Richter B, Blum S, Hülsmann M, Wojta J, Niessner A. The prognostic impact of crculating regulatory T lymphocytes on mortality in patients with ischemic heart failure with reduced ejection fraction. Mediators Inflamm. 2020;2020:6079713.
  • Kastl SP, Katsaros KM, Krychtiuk KA, Jägersberger G, Kaun C, Huber K, Wojta J, Speidl WS. The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitro. PLoS One. 2020;15:e0232483.
  • Lenz M, Draxler DF, Zhang C, Kassem M, Kastl SP, Niessner A, Huber K, Wojta  J, Heinz G, Speidl WS, Krychtiuk KA. Toll-like receptor 2 and 9 expression on circulating neutrophils is associated with increased mortality in critically ill patients. Shock. 2020;54:35-43.
  • Rega-Kaun G, Kaun C, Jaegersberger G, Prager M, Hackl M, Demyanets S, Wojta J, Hohensinner PJ. Roux-en-Y-bariatric surgery reduces markers of metabolic syndrome in morbidly obese patients. Obes Surg. 2020;30:391-400.
  • Stojkovic S, Koller L, Sulzgruber P, Hülsmann M, Huber K, Mayr M, Hengstenberg C, Wojta J, Niessner A. Liver-specific microRNA-122 as prognostic biomarker in patients with chronic systolic heart failure. Int J Cardiol. 2020;303:80-85.
  • Wojta J. Macrophages and Thrombin-Another Link between Inflammation and Coagulation. Thromb Haemost. 2020;120:537.

 

REM:

  • Kiss A, Heber S, Kramer AM, Hackl M, Skalicky S, Hallström S, Podesser BK, Santer D. MicroRNA Expression profile changes after cardiopulmonary bypass and ischemia/reperfusion-injury in a porcine model of cardioplegic arrest. Diagnostics. 2020;10:240.
  • Pilz PM, Lang M, Hamza O, Szabo PL, Inci M, Kramer AM, Koch M, Huber J, Podesser BK, Kiss A. Semi-minimal invasive method to induce myocardial infarction in rats and the assessment of cardiac function by an isolated working heart system. J Vis Exp. 2020;(160).
  • Podesser BK, De Paulis R. Implantability of a novel, pre-assembled aortic valved conduit with RESILIA™ tissue. J Cardiovasc Surg. 2020;61:376-379.

 

BIO:

  • Gremmel T, Huber K. Antithrombotic treatment strategies after PCI. Lancet. 2020;395:865.
  • Haller PM, Vargas KG, Haller MC, Piackova E, Wojta J, Gyöngyösi M, Gersh BJ, Kiss A, Podesser BK, Huber K. Remote ischaemic conditioning for myocardial infarction or elective PCI: systematic review and meta-analyses of randomized trials. Eur Heart J Acute Cardiovasc Care. 2020;9(1_suppl):82-92.
  • Hassager C, Price S, Huber K. Cardiac arrest in the COVID-19 era. Eur Heart J Acute Cardiovasc Care. 2020;9:239-240.
  • Huber K, Goldstein P. Covid-19: implications for prehospital, emergency and hospital care in patients with acute coronary syndromes. Eur Heart J Acute Cardiovasc Care. 2020;9:222-228.
  • Huber K, Ulmer H, Lang IM, Mühlberger V. Coronary interventions in Austria, Germany, and Switzerland. Eur Heart J. 2020;41:2599-2600.
  • Jäger B, Haller PM, Piackova E, Kaff A, Christ G, Schreiber W, Weidinger F, Stefenelli T, Delle-Karth G, Maurer G, Huber K; Vienna STEMI Registry Group. Predictors of transportation delay in patients with suspected ST-elevation- myocardial infarction in the VIENNA-STEMI network. Clin Res Cardiol. 2020;109:393-399.
  • Kaufmann CC, Wessely E, Huber K. Non-bacterial thrombotic endocarditis in the context of pulmonary adenocarcinoma: a case report. Eur Heart J Case Rep. 2020;4:1-5.
  • Stanetic BM, Ostojic M, Kovacevic-Preradovic T, Kos L, Stanetić K, Nikolic A, Bojic M, Huber K. ApPropRiateness of myOcardial revascUlarization assessed by SYNTAX Scores in patients with type 2 diabetes melliTus: the PROUST study. Postepy Kardiol Interwencyjnej. 2020;16:153-161.

ECP:

  • Eilenberg M, Enayati M, Ehebruster D, Grasl C, Walter I, Messner B, Baudis S, Potzmann P, Kaun C, Podesser BK, Wojta J, Bergmeister H. Long term evaluation of nanofibrous, bioabsorbable polycarbonate urethane grafts for small diameter vessel replacement in rodents. Eur J Vasc Endovasc Surg. 2020;59:643-652.

 

 

Associated publications of the LBI for Cardiovascular Research 2020

Original papers and reviews on which PIs or project-associated co-workers appear as co-authors (highlighted in bold) are considered to be associated publications of the instituter and are listed below.

  • Aman M, Bergmeister KD, Festin C, Sporer ME, Russold MF, Gstoettner C, Podesser BK, Gail A, Farina D, Cederna P, Aszmann OC. Experimental testing of bionic peripheral nerve and muscle interfaces: animal model considerations. Front Neurosci. 2020;13:1442.
  • Angiolillo DJ, Baber U, Sartori S, Briguori C, Dangas G, Cohen DJ, Mehta SR, Gibson CM, Chandiramani R, Huber K, Kornowski R, Weisz G, Kunadian V, Oldroyd KG, Ya-Ling H, Kaul U, Witzenbichler B, Dudek D, Sardella G, Escaned J, Sharma S, Shlofmitz RA, Collier T, Pocock S, Mehran R. Ticagrelor with or without aspirin in high-risk patients with diabetes mellitus undergoing percutaneous coronary intervention. J Am Coll Cardiol. 2020;75:2403-2413.
  • Bauer T, Zeymer U, Diallo A, Vicaut E, Bolognese L, Cequier A, Huber K, Montalescot G, Hamm CW, Van't Hof AW; ATLANTIC Investigators. Impact of preprocedural TIMI flow on clinical outcome in low-risk patients with ST-elevation myocardial infarction: Results from the ATLANTIC study. Catheter Cardiovasc Interv. 2020;95:494-500.
  • Bergmark BA, O'Donoghue ML, Murphy SA, Kuder JF, Ezhov MV, Ceška R, Gouni-Berthold I, Jensen HK, Tokgozoglu SL, Mach F, Huber K, Gaciong Z, Lewis BS, Schiele F, Jukema JW, Pedersen TR, Giugliano RP, Sabatine MS. An exploratory analysis of proprotein convertase subtilisin/kexin type 9 inhibition and aortic stenosis in the FOURIER trial. JAMA Cardiol. 2020;5:1–6.
  • Biesinger BS, Gasecka A, Perkmann T, Wojta J, Lesiak M, Grygier M, Eyileten C, Postuła M, Filipiak KJ, Toma A, Hengstenberg C, Siller-Matula JM. Inflammatory state does not affect the antiplatelet efficacy of potent P2Y12 inhibitors in ACS. Platelets. 2020;5:1-9.
  • Chieffo A, Stefanini GG, Price S, Barbato E, Tarantini G, Karam N, Moreno R, Buchanan GL, Gilard M, Halvorsen S, Huber K, James S, Neumann FJ, Möllmann H, Roffi M, Tavazzi G, Mauri Ferré J, Windecker S, Dudek D, Baumbach A. EAPCI Position statement on invasive management of acute coronary syndromes during the COVID-19 pandemic. Eur Heart J. 2020;41:1839-1851.
  • Dangas G, Baber U, Sharma S, Giustino G, Mehta S, Cohen DJ, Angiolillo DJ, Sartori S, Chandiramani R, Briguori C, Dudek D, Escaned J, Huber K, Collier T, Kornowski R, Kunadian V, Kaul U, Oldroyd K, Sardella G, Shlofmitz R, Witzenbichler B, Ya-Ling H, Pocock S, Gibson CM, Mehran R. Ticagrelor with or without aspirin after complex PCI. J Am Coll Cardiol. 2020;75:2414-2424.
  • Demyanets S, Stojkovic S, Mauracher LM, Kopp CW, Wojta J, Thaler J, Panzer S, Gremmel T. Surrogate markers of neutrophil extracellular trap formation are associated with ischemic outcomes and platelet activation after peripheral angioplasty and stenting. J Clin Med. 2020;9:304.
  • Ebner J, Cagalinec M, Kubista H, Todt H, Szabo PL, Kiss A, Podesser BK, Cserne Szappanos H, Hool LC, Hilber K, Koenig X. Neuronal nitric oxide synthase regulation of calcium cycling in ventricular cardiomyocytes is independent of Cav/1.2 channel modulation under basal conditions. Pflugers Arch. 2020;472:61-74.
  • Ebner J, Uhrin P, Szabo PL, Kiss A, Podesser BK, Todt H, Hilber K, Koenig X. Reduced Na+ current in Purkinje fibers explains cardiac conduction defects and arrhythmias in Duchenne muscular dystrophy. Am J Physiol Heart Circ Physiol. 2020;318:H1436-H1440.
  • Ehrmann K, Potzmann P, Dworak C, Bergmeister H, Eilenberg M, Grasl C, Koch T, Schima H, Liska R, Baudis S. Hard block degradable polycarbonate urethanes: promising biomaterials for electrospun vascular prostheses. Biomacromolecules. 2020;21:376-387.
  • Feistritzer HJ, Desch S, Freund A, Poess J, Zeymer U, Ouarrak T, Schneider S, de Waha-Thiele S, Fuernau G, Eitel I, Noc M, Stepinska J, Huber K, Thiele H. Prognostic impact of active mechanical circulatory support in cardiogenic shock complicating acute myocardial infarction, results from the culprit-shock trial. J Clin Med. 2020;9:E1976.
  • Freund A, Jobs A, Lurz P, Feistritzer HJ, de Waha-Thiele S, Meyer-Saraei R, Montalescot G, Huber K, Noc M, Windecker S, Zeymer U, Ouarrak T, Schneider S, Thiele H, Desch S. Frequenc and impact of bleeding on outcome in patients with cardiogenic shock. JACC Cardiovasc Interv. 2020;13:1182-1193.
  • Göschl L, Preglej T, Boucheron N, Saferding V, Müller L, Platzer A, Hirahara K, Shih HY, Backlund J, Matthias P, Niederreiter B, Hladik A, Kugler M, Gualdoni GA, Scheinecker C, Knapp S, Seiser C, Holmdahl R, Tillmann K, Plasenzotti R, Podesser B, Aletaha D, Smolen JS, Karonitsch T, Steiner G, Ellmeier W, Bonelli M. Histone deacetylase 1 (HDAC1): A key player of T cell-mediated arthritis. J Autoimmun. 2020;108:102379.
  • Kozieł M, Merino JL, De Caterina R, Huber K, Jin J, Melino M, Goette A, Lip GYH; ENSURE-AF Investigators. Comparing TEE- vs Non-TEE-guided cardioversion of atrial fibrillation: The ENSURE-AF trial. Eur J Clin Invest. 2020;50:e13221.
  • Mair J, Cullen L, Giannitsis E, Hammarsten O, Huber K, Jaffe A, Mills N, Möckel M, Müller C, Thygesen K, Lindahl B. Application of the fourth universal definition of myocardial infarction in clinical practice. Biomarkers. 2020;25:322-330.
  • Roth C, Krychtiuk KA, Gangl C, Schrutka L, Distelmaier K, Wojta J, Hengstenberg C, Berger R, Speidl WS. Lipoprotein(a) plasma levels are not associated with survival after acute coronary syndromes: An observational cohort study. PLoS One. 2020;15:e0227054.
  • Rubini Giménez M, Miller PE, Alviar CL, van Diepen S, Granger CB, Montalescot G, Windecker S, Maier L, Serpytis P, Serpytis R, Oldroyd KG, Noc M, Fuernau G, Huber K, Sandri M, de Waha-Thiele S, Schneider S, Ouarrak T, Zeymer U, Desch S, Thiele H. Outcomes associated with respiratory failure for patients with cardiogenic shock and acute myocardial infarction: A substudy of the CULPRIT-SHOCK trial. J Clin Med. 2020;9:860.
  • Rubini Gimenez M, Zeymer U, Desch S, de Waha-Thiele S, Ouarrak T, Poess J, Meyer-Saraei R, Schneider S, Fuernau G, Stepinska J, Huber K, Windecker S, Montalescot G, Savonitto S, Jeger RV, Thiele H. Sex-Specific Management in patients with acute myocardial infarction and cardiogenic shock: A substudy of the CULPRIT-SHOCK trial. Circ Cardiovasc Interv. 2020;13:e008537.
  • Takahashi K, Kogame N, Tomaniak M, Chichareon P, Chang CC, Modolo R, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, van Geuns RJ, Dominici M, Huber K, Buszman P, Bolognese L, Tumscitz C, Żmudka K, Aminian A, Vrolix M, Petrov I, Wykrzykowska JJ, de Winter RJ, Hamm C, Steg PG, Onuma Y, Valgimigli M, Windecker S, Vranckx P, Garg S, Serruys PW. Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial. Clin Res Cardiol. 2020;109:918-929.
  • Tavenier AH, Hermanides RS, Fabris E, Lapostolle F, Silvain J, Ten Berg JM, Lassen JF, Bolognese L, Cantor WJ, Cequier Á, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Ecollan P, Collet JP, Willems FF, Diallo A, Vicaut E, Hamm CW, Montalescot G, van 't Hof AWJ; ATLANTIC investigators. Efficacy and safety of glycoprotein IIb/IIIa inhibitors on top of ticagrelor in STEMI: A subanalysis of the ATLANTIC trial. Thromb Haemost. 2020;120:65-74.
  • Wernly B, Paar V, Aigner A, Pilz PM, Podesser BK, Förster M, Jung C, Hofbauer JP, Tockner B, Wimmer M, Kraus T, Motloch LJ, Hackl M, Hoppe UC, Kiss A, Lichtenauer M. Anti-CD3 antibody treatment reduces scar formation in a rat model of myocardial infarction. Cells. 2020;9:295.
  • Wohlrab P, Boehme S, Kaun C, Wojta J, Spittler A, Saleh L, Knöfler M, Markstaller K, Klein KU, Tretter V. Ropivacaine activates multiple proapoptotic and inflammatory signaling pathways that might subsume to trigger epidural-related maternal fever. Anesth Analg. 2020;130:321-331.
  • Zeymer U, Bueno H, Granger CB, Hochman J, Huber K, Lettino M, Price S, Schiele F, Tubaro M, Vranckx P, Zahger D, Thiele H. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology. Eur Heart J Acute Cardiovasc Care. 2020;9:183-197.

 

Publications of the LBI for Cardiovascular Research 2019

Only original papers or reviews on which either a PI or one of his/her co-workers associated with the respective project appear as first, last or corresponding author (highlighted in bold) are considered be publications of the institute.

Publications ASC:

  • Granegger M, Thamsen B, Moscato F, Schlöglhofer T, Gross C, Schneider S, Röhrich M, Kertzscher U, Zimpfer D, Affeld K, Schima H. Noninvasive assessment of blood pressure in rotary blood pump recipients using a novel ultrasonic Doppler method. Int J Artif Organs. 2019;42:226-232.
  • Gross C, Marko C, Mikl J, Altenberger J, Schlöglhofer T, Schima H, Zimpfer D, Moscato F. LVAD pump flow does not adequately increase with exercise. Artif Organs. 2019;43:222-228.

 

Publications INFO:

  • Rega-Kaun G, Kaun C, Ebenbauer B, Jaegersberger G, Prager M, Wojta J, Hohensinner PJ. Bariatric surgery in morbidly obese individuals affects plasma levels of protein C and thrombomodulin. J Thromb Thrombolysis. 2019;47:51-56.
  • Rega-Kaun G, Ritzel D, Kaun C, Ebenbauer B, Thaler B, Prager M, Demyanets S, Wojta J, Hohensinner PJ. Changes of circulating extracellular vesicles from the liver after Roux-en-Y bariatric surgery. Int J Mol Sci. 2019;20:2153.
  • Sulzgruber P, Schnaubelt S, Koller L, Goliasch G, Niederdöckl J, Simon A, El-Hamid F, Rothgerber DJ, Wojta J, Niessner A. Cardiac arrest as an age-dependent prognosticator for long-term mortality after acute myocardial infarction: the potential impact of infarction size. Eur Heart J Acute Cardiovasc Care. 2019;8:153-160.
  • Thaler B, Baik N, Hohensinner PJ, Baumgartner J, Panzenböck A, Stojkovic S, Demyanets S, Huk I, Rega-Kaun G, Kaun C, Prager M, Fischer MB, Huber K, Speidl WS, Parmer RJ, Miles LA, Wojta J. Differential expression of Plg-RKT and its effects on migration of proinflammatory monocyte and macrophage subsets. Blood. 2019;134:561-567.
  • Thaler B, Hohensinner PJ, Baumgartner J, Haider P, Krychtiuk KA, Schörgenhofer C, Jilma B, Hell L, Fischer MB, Huber K, Hengstenberg C, Speidl WS, Wojta J. Protease-activated receptors 1 and 3 are differentially expressed on human monocyte subsets and are upregulated by lipopolysaccharide ex vivo and in vivo. Thromb Haemost. 2019;119:1394-1402.

 

Publications REM:

  • Gonçalves IF, Acar E, Costantino S, Szabo PL, Hamza O, Tretter EV, Klein KU, Trojanek S, Abraham D, Paneni F, Hallström S, Kiss A, Podesser BK. Epigenetic modulation of tenascin C in the heart: implications on myocardial ischemia, hypertrophy and metabolism. J Hypertens. 2019;37:1861-1870.
  • Hamza O, Kiss A, Kramer AM, Tillmann KE, Podesser BK. Characterization of a novel percutaneous closed chest swine model of ischemic mitral regurgitation guided by contrast echocardiography. EuroIntervention. 2019 Jun 25:EIJ-D-19-00095.
  • Kiss A, Podesser BK. Cardioprotection by PEDF: A novel form of GLUT4 membrane translocation to reduce myocardial ischemic injury. Int J Cardiol. 2019;288:119-120.
  • Nagel F, Santer D, Stojkovic S, Kaun C, Schaefer AK, Krššák M, Abraham D, Bencsik P, Ferdinandy P, Kenyeres E, Szabados T, Wojta J, Trescher K, Kiss A, Podesser BK. The impact of age on cardiac function and extracellular matrix component expression in adverse post-infarction remodeling in mice. Exp Gerontol. 2019;119:193-202.
  • Pilz PM, Hamza O, Gidlöf O, Gonçalves IF, Tretter EV, Trojanek S, Abraham D, Heber S, Haller PM, Podesser BK, Kiss A. Remote ischemic perconditioning attenuates adverse cardiac remodeling and preserves left ventricular function in a rat model of reperfused myocardial infarction. Int J Cardiol. 2019;285:72-79.
  • Santer D, Kramer A, Kiss A, Aumayr K, Hackl M, Heber S, Chambers DJ, Hallström S, Podesser BK. St Thomas' Hospital polarizing blood cardioplegia improves hemodynamic recovery in a porcine model of cardiopulmonary bypass. JThorac Cardiovasc Surg. 2019;158:1543-1554.

 

Publications BIO:

  • Egger F, Hofer C, Hammerle FP, Löfler S, Nürnberg M, Fiedler L, Kriz R, Kern H, Huber K. Influence of electrical stimulation therapy on permanent pacemaker function. Wien Klin Wochenschr. 2019;131:313-320
  • Gruber SC, Freynhofer MK, Willheim M, Weiss TW, Egger F, Hübl W, Huber K. Twenty-four-hour time dependency of clopidogrel effects in patients with acute coronary syndromes: The CiCAD-Study. Platelets. 2019;30:506-512.
  • Haller PM, Stojkovic S, Piackova E, Andric T, Wisgrill L, Spittler A, Wojta J, Huber K, Jäger B. The association of P2Y12 inhibitors with pro- coagulatory extracellular vesicles and microRNAs in stable coronary artery disease. Platelets. 2020;31:497-504.
  • Jäger B, Piackova E, Haller PM, Andric T, Kahl B, Christ G, Geppert A, Wojta J, Huber K. Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy. Arch Med Sci. 2019;15:65-71.
  • Jäger B, Stojkovic S, Haller PM, Piackova E, Kahl BS, Andric T, Vargas KG, Wojta J, Huber K. Course of platelet miRNAs after cessation of P2Y12 antagonists. Eur J Clin Invest. 2019;49:e13149.
  • Kaufmann CC, Lyon AR, Wojta J, Huber K. Is P2Y12 inhibitor therapy associated with an increased risk of cancer? Eur Heart J Cardiovasc Pharmacother. 2019;5:100-104.
  • Lip GYH, Collet JP, Haude M, Byrne R, Chung EH, Fauchier L, Halvorsen S, Lau D, Lopez-Cabanillas N, Lettino M, Marin F, Obel I, Rubboli A, Storey RF, Valgimigli M, Huber K; ESC Scientific Document Group. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace. 2019;21:192-193.
  • Stojkovic S, Nossent AY, Haller P, Jäger B, Vargas KG, Wojta J, Huber K. MicroRNAs as regulators and biomarkers of platelet function and activity in coronary artery disease. Thromb Haemost. 2019;119:1563-1572.
  • Tscharre M, Herman R, Rohla M, Piackova E, Vargas KG, Farhan S, Freynhofer MK, Weiss TW, Huber K. Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention. J Clin Lipidol. 2019;13:115-122.
  • Vargas KG, Haller PM, Jäger B, Tscharre M, Binder RK, Mueller C, Lindahl B, Huber K. Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis. Clin Res Cardiol. 2019;108:749-762.

Associated publications of the LBI for Cardiovascular Research 2019

Original papers and reviews on which PIs or project-associated co-workers appear as co-authors (highlighted in bold) are considered to be associated publications of the institute and are listed below.

  • Aimo A, Januzzi JL Jr, Vergaro G, Clerico A, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Ueland T, Nymo SH, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Ripoli A, Passino C, Emdin M. Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome. Eur J Prev Cardiol. 2019;26:1751-1759.
  • Aimo A, Januzzi JL Jr, Vergaro G, Ripoli A, Latini R, Masson S, Magnoli M, Anand IS, Cohn JN, Tavazzi L, Tognoni G, Gravning J, Ueland T, Nymo SH, Rocca HB, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Wilson Tang WH, Grodin JL, Passino C, Emdin M. High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure. Int J Cardiol. 2019;277:166-172.
  • Åkerblom A, Wojdyla D, Steg PG, Wallentin L, James SK, Budaj A, Katus HA, Himmelmann A, Huber K, Siegbahn A, Storey RF, Becker RC; PLATO Investigators. Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. J Thromb Thrombolysis. 2019;48:563-569.
  • Aradi D, Gross L, Trenk D, Geisler T, Merkely B, Kiss RG, Komócsi A, Dézsi CA, Ruzsa Z, Ungi I, Rizas KD, May AE, Mügge A, Zeiher AM, Holdt L, Huber K, Neumann FJ, Koltowski L, Huczek Z, Hadamitzky M, Massberg S, Sibbing D. Platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel: a pre-specified exploratory analysis from the TROPICAL-ACS trial. Eur Heart J. 2019;40:1942-1951.
  • Basic J, Stojkovic S, Assadian A, Rauscher S, Duschek N, Kaun C, Wojta J, Falkensammer J. The relevance of vascular endothelial growth factor, hypoxia inducible factor-1 alpha, and clusterin in carotid plaque instability. J Stroke Cerebrovasc Dis. 2019;28:1540-1545.
  • Beygui F, Castren M, Brunetti ND, Rosell-Ortiz F, Christ M, Zeymer U, Huber K, Folke F, Svensson L, Bueno H, Van't Hof A, Nikolaou N, Nibbe L, Charpentier S, Swahn E, Tubaro M, Goldstein P; ACCA study group on pre-hospital care. Pre-hospital management of patients with chest pain and/or dyspnoea of cardiac origin. A position paper of the Acute Cardiovascular Care Association (ACCA) of the ESC. Eur Heart J Acute Cardiovasc Care. 2020;9(1_suppl):59-81.
  • Capodanno D, Huber K, Mehran R, Lip GYH, Faxon DP, Granger CB, Vranckx P, Lopes RD, Montalescot G, Cannon CP, Ten Berg J, Gersh BJ, Bhatt DL, Angiolillo DJ. Management of antithrombotic therapy in atrial fibrillation patients undergoing PCI: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74:83-99.
  • Christersson C, Wallentin L, Andersson U, Alexander JH, Alings M, De Caterina R, Gersh BJ, Granger CB, Halvorsen S, Hanna M, Huber K, Hylek EM, Lopes RD, Oh BH, Siegbahn A. Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation. Heart. 2019;105:235-242.
  • Citro A, Moser PT, Dugnani E, Rajab TK, Ren X, Evangelista-Leite D, Charest JM, Peloso A, Podesser BK, Manenti F, Pellegrini S, Piemonti L, Ott HC. Biofabrication of a vascularized islet organ for type 1 diabetes. Biomaterials. 2019;199:40-51.
  • Clifford R, Robson D, Gross C, Moscato F, Schima H, Jansz P, Macdonald PS, Hayward CS. Beat-to beat detection of aortic valve opening in HeartWare left ventricular assist device patients. Artif Organs. 2019;43:458-466.
  • Drexel H, Rosano GMC, Lewis BS, Huber K, Vonbank A, Dopheide JF, Mader A, Niessner A, Savarese G, Wassmann S, Agewall S. The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials. Eur Heart J Cardiovasc Pharmacother. 2020;6:97-103.
  • Eilenberg W, Stojkovic S, Kaider A, Piechota-Polanczyk A, Nanobachvili J, Domenig CM, Wojta J, Huk I, Demyanets S, Neumayer C. Neutrophil g elatinae associated lipocalin (NGAL) for identification of unstable plaques in patients with asymptomatic carotid stenosis. Eur J Vasc Endovasc Surg. 2019;57:768-777.
  • Fabris E, Van't Hof A, Hamm CW, Lapostolle F, Lassen JF, Goodman SG, Ten Berg JM, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Cantor WJ, Kerneis M, Diallo A, Vicaut E, Montalescot G; ATLANTIC investigators. Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial. Catheter Cardiovasc Interv. 2019;93:E369-E377.
  • Fabris E, van 't Hof A, Hamm CW, Lapostolle F, Lassen JF, Goodman SG, Ten Berg JM, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Cantor WJ, Tsatsaris A, Kerneis M, Diallo A, Vicaut E, Montalescot G. Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC Trial. Eur Heart J Acute Cardiovasc Care. 2019;8:208-217.
  • Feistritzer HJ, Desch S, Zeymer U, Fuernau G, de Waha-Thiele S, Dudek D, Huber K, Stepinska J, Schneider S, Ouarrak T, Thiele H. Prognostic impact of atrial fibrillation in acute myocardial infarction and cardiogenic shock. Circ Cardiovasc Interv. 2019;12:e007661.
  • Franzone A, McFadden E, Leonardi S, Piccolo R, Vranckx P, Serruys PW, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, Diletti R, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Hamm C, Steg PG, Heg D, Jüni P, Windecker S, Valgimigli M; GLASSY Investigators. Ticagrelor alone versus dual antiplatelet therapy from 1 month after drug-eluting coronary stenting. J Am Coll Cardiol. 2019;74:2223-2234.
  • Freynhofer MK, Hein-Rothweiler R, Haller PM, Aradi D, Dézsi DA, Gross L, Orban M, Trenk D, Geisler T, Huczek Z, Toth-Gayor GG, Massberg S, Huber K, Sibbing D. Diurnal variability of on-treatment platelet reactivity in clopidogrel versus prasugrel Ttreated acute coronary syndrome patients: A pre-specified TROPICAL-ACS sub-study. Thromb Haemost. 2019;119:660-667.
  • Giannitsis E, Clifford P, Slagman A, Ruedelstein R, Liebetrau C, Hamm C, Honnart D, Huber K, Vollert JO, Simonelli C, Schröder M, Wiemer JC, Mueller-Hennessen M, Schroer H, Kastner K, Möckel M. Multicentre cross-sectional observational registry to monitor the safety of early discharge after rule-out of acute myocardial infarction by copeptin and troponin: the Pro-Core registry. BMJ Open. 2019;9:e028311.
  • Geisler T, Jorbenadze R, Popov AF, Mueller KL, Rath D, Droppa M, Schreieck J, Seizer P, Storey RF, Kristensen SD, Rubboli A, Gorog D, Aradi D, Sibbing D, Huber K, Gawaz M, Ten Berg J. Thrombogenicity and antithrombotic strategies in structural heart interventions and nonaortic cardiac device therapy-current evidence and practice. Thromb Haemost. 2019;119:1590-1605.
  • Goldstein SA, Green J, Huber K, Wojdyla DM, Lopes RD, Alexander JH, Vinereanu D, Wallentin L, Granger CB, Al-Khatib SM. Characteristics and outcomes of atrial fibrillation in patients with thyroid disease (from the ARISTOTLE trial). Am J Cardiol. 2019;124:1406-1412.
  • Goncalves-Alves E, Saferding V, Schliehe C, Benson R, Kurowska-Stolarska M, Brunner JS, Puchner A, Podesser BK, Smolen JS, Redlich K, Bonelli M, Brewer J, Bergthaler A, Steiner G, Blüml S. MicroRNA-155 controls T helper cell activation during viral infection. Front Immunol. 2019;10:1367.
  • Gross L, Kupka D, Trenk D, Geisler T, Hadamitzky M, Löw A, Orban M, Huber K, Kiss RG, Merkely B, Huczek Z, Beuthner BE, Hein-Rothweiler R, Baylacher M, Rizas K, Massberg S, Aradi D, Sibbing D, Jacobshagen C. Gender and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients: The TROPICAL-ACS gender substudy. Thromb Haemost. 2019;119:1527-1538.
  • Håkansson KEJ, Goossens EAC, Trompet S, van Ingen E, de Vries MR, van der Kwast RVCT, Ripa RS, Kastrup J, Hohensinner PJ, Kaun C, Wojta J, Böhringer S, Le Cessie S, Jukema JW, Quax PHA, Nossent AY. Genetic associations and regulation of expression indicate an independent role for 14q32 snoRNAs in human cardiovascular disease. Cardiovasc Res. 2019;115:1519-1532.
  • Haller PM, Sulzgruber P, Kaufmann C, Geelhoed B, Tamargo J, Wassmann S, Schnabel RB, Westermann D, Huber K, Niessner A, Gremmel T. Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2019;5:226-236.
  • Hayer S, Zeilinger M, Weiss V, Dumanic M, Seibt M, Niederreiter B, Shvets T, Pichler F, Wadsak W, Podesser BK, Helbich TH, Hacker M, Smolen JS, Redlich K, Mitterhauser M. Multimodal [18F]FDG PET/CT is a direct readout for inflammatory bone repair: A longitudinal study in TNFα transgenic mice. J Bone Miner Res. 2019;34:1632-1645.
  • Kaniusas E, Kampusch S, Tittgemeyer M, Panetsos F, Gines RF, Papa M, Kiss A, Podesser B, Cassara AM, Tanghe E, Samoudi AM, Tarnaud T, Joseph W, Marozas V, Lukosevicius A, Ištuk N, Lechner S, Klonowski W, Varoneckas G, Széles JC, Šarolić A. Current directions in the auricular vagus nerve stimulation II – an engineering Perspective. Front Neurosci. 2019;13:772.
  • Kaniusas E, Kampusch S, Tittgemeyer M, Panetsos F, Gines RF, Papa M, Kiss A, Podesser B, Cassara AM, Tanghe E, Samoudi AM, Tarnaud T, Joseph W, Marozas V, Lukosevicius A, Ištuk N, Šarolić A, Lechner S, Klonowski W, Varoneckas G, Széles JC. Current directions in the auricular vagus nerve stimulation I – a physiological perspective. Front Neurosci. 2019;13:854.
  • Kastl SP, Krychtiuk KA, Lenz M, Distelmaier K, Goliasch G, Huber K, Wojta J, Heinz G, Speidl WS. Intestinal fatty acid binding protein is associated with mortality in patients with acute heart failure or cardiogenic shock. Shock. 2019;51:410-415.
  • Koltowski L, Tomaniak M, Gross L, Rymuza B, Kowara M, Parma R, Komosa A, Klopotowski M, Jacobshagen C, Gori T, Aradi D, Huber K, Hadamitzky M, Massberg S, Lesiak M, Filipiak KJ, Witkowski A, Opolski G, Huczek Z, Sibbing D. Guided de-escalation of DAPT in acute coronary syndrome patients undergoing percutaneous coronary intervention with BVS implantation: a post-hoc analysis from the randomized TROPICAL-ACS trial. J Thromb Thrombolysis. 2019;47:427-435.
  • Krychtiuk KA, Huber K, Leonardi S. Acute Cardiovascular Care 2019. Eur Heart J. 2019;40:1903-1906.
  • Lapostolle F, Van't Hof AW, Hamm CW, Stibbe O, Ecollan P, Collet JP, Silvain J, Lassen JF, Heutz WMJM, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Ten Berg J, Zeymer U, Licour M, Tsatsaris A, Montalescot G; ATLANTIC Investigators. Morphine and ticagrelor interaction in primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: ATLANTIC-morphine. Am J Cardiovasc Drugs. 2019;19:173-183.
  • Leonardi S, Franzone A, Piccolo R, McFadden E, Vranckx P, Serruys P, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, van Geuns RJ, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Hamm C, Steg G, Heg D, Juni P, Windecker S, Valgimigli M. Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY). BMJ Open. 2019;9:e026053.
  • Leutner M, Tscharre M, Farhan S, Taghizadeh Waghefi H, Harreiter J, Vogel B, Tentzeris I, Szekeres T, Fritzer-Szekeres M, Huber K, Kautzky-Willer A. A Sex- Specific analysis of the predictive value of troponin I and T in patients with and without diabetes mellitus after successful coronary intervention. Front Endocrinol. 2019;10:105.
  • Nossent AY, Ektefaie N, Wojta J, Eichelberger B, Kopp C, Panzer S, Gremmel T. Plasma levels of snoRNAs are associated with platelet activation in patients with peripheral artery disease. Int J Mol Sci. 2019;20:5975.
  • Orban M, Trenk D, Geisler T, Rieber J, Hadamitzky M, Gross L, Orban M, Kupka D, Baylacher M, Müller S, Huber K, Koltowski L, Huczek Z, Heyn J, Jacobshagen C, Aradi D, Massberg S, Sibbing D, Hein R; TROPICAL-ACS Investigators. Smoking and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients: A substudy from the randomized TROPICAL-ACS trial. Eur Heart J Cardiovasc Pharmacother. 2019:pvz084.
  • O'Donoghue ML, Fazio S, Giugliano RP, Stroes ESG, Kanevsky E, Gouni-Berthold I, Im K, Lira Pineda A, Wasserman SM, Češka R, Ezhov MV, Jukema JW, Jensen HK, Tokgözoğlu SL, Mach F, Huber K, Sever PS, Keech AC, Pedersen TR, Sabatine MS. Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk. Circulation. 2019;139:1483-1492.
  • Osmanagic-Myers S, Kiss A, Manakanatas C, Hamza O, Sedlmayer F, Szabo PL, Fischer I, Fichtinger P, Podesser BK, Eriksson M, Foisner R. Endothelial progerin expression causes cardiovascular pathology through an impaired mechanoresponse. J Clin Invest. 2019;129:531-545.
  • Patti G, Pecen L, Lucerna M, Huber K, Rohla M, Renda G, Siller-Matula J, Ricci F, Kirchhof P, De Caterina R. Net clinical benefit of non-vitamin K antagonist vs vitamin K antagonist anticoagulants in elderly patients with atrial fibrillation. Am J Med. 2019;132:749-757.
  • Puhm F, Afonyushkin T, Resch U, Obermayer G, Rohde M, Penz T, Schuster M, Wagner G, Rendeiro AF, Melki I, Kaun C, Wojta J, Bock C, Jilma B, Mackman N, Boilard E, Binder CJ. Mitochondria are a subset of extracellular vesicles released by activated monocytes and induce type I IFN and TNF responses in endothelial cells. Circ Res. 2019;125:43-52.
  • Richter B, Sulzgruber P, Koller L, Steininger M, El-Hamid F, Rothgerber DJ, Forster S, Goliasch G, Silbert BI, Meyer EL, Hengstenberg C, Wojta J, Niessner A. Blood urea nitrogen has additive value beyond estimated glomerular filtration rate for prediction of long-term mortality in patients with acute myocardial infarction. Eur J Intern Med. 2019;59:84-90.
  • Richter B, Uray T, Krychtiuk KA, Schriefl C, Lenz M, Nürnberger A, Kastl SP, Wojta J, Heinz G, Schwameis M, Speidl WS. Growth differentiation factor-15 predicts poor survival after cardiac arrest. Resuscitation. 2019;143:22-28.
  • Rohla M, Weiss TW, Pecen L, Patti G, Siller-Matula JM, Schnabel RB, Schilling R, Kotecha D, Lucerna M, Huber K, De Caterina R, Kirchhof P. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).BMJ Open. 2019;9:e022478.
  • Tillmann K, Windschnurer I, Gamper J, Hinney B, Rülicke T, Podesser BK, Troxler J, Plasenzotti R. Welfare assessment in rabbits raised for meat and laboratory purposes in enclosures with two floor types: Perforated plastic with holes versus slats. Res Vet Sci. 2019;122:200-209.
  • Tscharre M, Farhan S, Bruno V, Rohla M, Egger F, Weiss TW, Hübl W, Willheim M, Wojta J, Geppert A, Huber K, Freynhofer MK. Impact of platelet turnover on long-term adverse cardiovascular outcomes in patients undergoing percutaneous coronary intervention. Eur J Clin Invest. 2019;49:e13157.
  • Tscharre M, Vogel B, Tentzeris I, Freynhofer MK, Rohla M, Wojta J, Weiss TW, Ay C, Huber K, Farhan S. Prognostic impact of soluble P-selectin on long-term adverse cardiovascular outcomes in patients undergoing percutaneous coronary intervention. Thromb Haemost. 2019;119:340-347.
  • Wadowski PP, Pultar J, Weikert C, Eichelberger B, Panzer B, Huber K, Lang IM, Koppensteiner R, Panzer S, Gremmel T. Protease-activated receptor-mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors. Res Pract Thromb Haemost. 2019;3:383-390.
  • Wadowski PP, Steinlechner B, Zimpfer D, Schlöglhofer T, Schima H, Hülsmann M, Lang IM, Gremmel T, Koppensteiner R, Zehetmayer S, Weikert C, Pultar J, Jilma B. Functional capillary impairment in patients with ventricular assist devices. Sci Rep. 2019;9:5909.
  • Wernly B, Mirna M, Rezar R, Prodinger C, Jung C, Podesser BK, Kiss A, Hoppe UC, Lichtenauer M. Regenerative cardiovascular therapies: Stem cells and beyond. Int J Mol Sci. 2019;20:1420.
  • Windecker S, Lopes RD, Massaro T, Jones-Burton C, Granger CB, Aronson R, Heizer G, Goodman SG, Darius H, Jones WS, Aschermann M, Brieger D, Cura F, Engstrøm T, Fridrich V, Halvorsen S, Huber K, Kang HJ, Leiva-Pons JL, Lewis BS, Malaga G, Meneveau N, Merkely B, Milicic D, Morais J, Potpara TS, Raev D, Sabaté M, de Waha-Thiele S, Welsh RC, Xavier D, Mehran R, Alexander JH; AUGUSTUS Investigators. Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome treated medically or with percutaneous coronary intervention or undergoing elective percutaneous coronary intervention: Insights from the AUGUSTUS trial. Circulation. 2019;140:1921-1932.
  • Zagrapan B, Eilenberg W, Prausmueller S, Nawrozi P, Muench K, Hetzer S, Elleder V, Rajic R, Juster F, Martelanz L, Hayden H, Klopf J, Inan C, Teubenbacher P, Weigl MP, Kirchweger P, Beitzke D, Jilma B, Wojta J, Bailey MA, Scott DJA, Huk I, Neumayer C, Brostjan C. A novel diagnostic and prognostic score for abdominal aortic aneurysms based on D-dimer and a comprehensive analysis of myeloid cell parameters. Thromb Haemost. 2019;119:807-820.
  • Zlabinger K, Spannbauer A, Traxler D, Gugerell A, Lukovic D, Winkler J, Mester-Tonczar J, Podesser B, Gyöngyösi M. MiR-21, MiR-29a, GATA4, and MEF2c Expression Changes in Endothelin-1 and Angiotensin II Cardiac Hypertrophy Stimulated Isl-1+Sca-1+c-kit+ porcine cardiac progenitor cells in vitro. Cells. 2019;8:1416.

Publications of the LBI for Cardiovascular Research 2018

Only original papers or reviews on which either a PI or one of his/her co-workers associated with the respective project appear as first, last or corresponding author (highlighted in bold) are considered to be publications of the cluster.

Publications ASC:

  • Gross C, Marko C, Mikl J, Altenberger J, Schlöglhofer T, Schima H, Zimpfer D, Moscato F. LVAD pump flow does not adequately increase with exercise. Artif Organs. 2019;43:222-228. IF= 2,379
  • Schlöglhofer T, Horvat J, Moscato F, Hartner Z, Necid G, Schwingenschlögl H, Riebandt J, Dimitrov K, Angleitner P, Wiedemann D, Laufer G, Zimpfer D, Schima H. A standardized telephone intervention algorithm improves the survival of ventricular assist device outpatients. Artif Organs. 2018;42:961-969. IF 2.379

Publications INFO:

  • Hohensinner PJ, Baumgartner J, Ebenbauer B, Thaler B, Fischer MB, Huber K, Speidl WS, Wojta J. Statin treatment reduces matrix degradation capacity of proinflammatory polarized macrophages. Vascul Pharmacol. 2018;110:49-54. IF 3.330
  • Hohensinner PJ, Kaun C, Ebenbauer B, Hackl M, Demyanets S, Richter D, Prager M, Wojta J, Rega-Kaun G. Reduction of premature aging markers after gastric bypass surgery in morbidly obese patients. Obes Surg. 2018;28:2804-2810. IF 3.603
  • Krychtiuk KA, Stojkovic S, Lenz M, Brekalo M, Huber K, Wojta J, Heinz G, Demyanets S, Speidl WS. Predictive value of low interleukin-33 in critically ill patients. Cytokine. 2018;103:109-113. IF 3.078
  • Stojkovic S, Kaider A, Koller L, Brekalo M, Wojta J, Diedrich A, Demyanets S, Pezawas T. GDF-15 is a better complimentary marker for risk stratification of arrhythmic death in non-ischaemic, dilated cardiomyopathy than soluble ST2. J Cell Mol Med. 2018;22:2422-2429. IF 4.658
  • Wojta J, Guzik T, Pearson JD. Pushing the frontiers of cardiovascular biology. Cardiovasc Res. 2018;114(3):e22. IF 7.014

Publications REM:

  • Bergmeister KD, Aman M, Podesser BK. Restricted working hours in Austrian residency programs : Survey results. Wien Klin Wochenschr. 2018;130:404-407. IF 1.170
  • Kiss A, Podesser BK. Low-dose of relaxin protects against arrhythmias and adverse left ventricle remodeling. Int J Cardiol. 2018;250:60-61. IF 3.471
  • Kiss A, Shu H, Hamza O, Santer D, Tretter EV, Yao S, Markstaller K, Hallström S, Podesser BK, Klein KU. Argon preconditioning enhances postischaemic cardiac functional recovery following cardioplegic arrest and global cold ischaemia. Eur J Cardiothorac Surg. 2018;54:539-546. IF 3.847
  • Podesser BK, Kreibich M, Dzilic E, Santer D, Förster L, Trojanek S, Abraham D, Krššák M, Klein KU, Tretter EV, Kaun C, Wojta J, Kapeller B, Gonçalves IF, Trescher K, Kiss A. Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis. J Hypertens. 2018;36:847-856. IF 4.209

Publications BIO:

  • Alber HF, Huber K. Changes and innovations of the 2017 ESC guidelines on dual antiplatelet therapy in coronary artery disease-a review. Wien Klin Wochenschr. 2018;130:694-697. IF 1.170
  • Egger F, Zweiker D, Freynhofer MK, Löffler V, Rohla M, Geppert A, Farhan S, Vogel B, Falkensammer J, Kastner J, Pichler P, Vock P, Lamm G, Luha O, Schmidt A, Scherr D, Hammerer M, Hoppe UC, Maurer E, Grund M, Lambert T, Tkalec W, Sturmberger T, Zeindlhofer E, Grabenwöger M, Huber K; Austrian TAVI Group. Impact of on-site cardiac surgery on clinical outcomes after transfemoral transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018 Nov 12;11(21):2160-2167. IF 9.544
  • Haller PM, Jäger B, Farhan S, Christ G, Schreiber W, Weidinger F, Stefenelli T, Delle-Karth G, Kaff A, Maurer G, Huber K, for the Vienna STEMI Registry Group. Impact of age on short- and long-term mortality of patients with ST-elevation myocardial infarction in the Vienna STEMI Network. Wien Klin Wochenschr. 2018;130:172-181. IF 1.170
  • Haller PM, Vargas KG, Haller MC, Piackova E, Wojta J, Gyöngyösi M, Gersh BJ, Kiss A, Podesser BK, Huber K. Remote ischaemic conditioning for myocardial infarction or elective PCI: systematic review and meta-analyses of randomized trials. Eur Heart J Acute Cardiovasc Care. 2018:2048872618784150. IF 3.734
  • Huber K. Current definitions of non-ST-segment elevation myocardial infarction: challenges for further improvement. JACC Cardiovasc Interv. 2018 May 14;11(9):865-867. IF 9.544
  • Huber K. Is Treatment of ST-segment-elevation myocardial infarction patients with ticagrelor or other P2Y(12) inhibitors before primary percutaneous coronary intervention a strategy without benefit? Circ Cardiovasc Interv. 2018;11:e006555. IF 6.060
  • Lip GYH, Collet JP, Haude M, Huber K. Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI: A Summary of the Joint Consensus Document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Eur Heart J. 2018;39:2847-2850. IF 23.239
  • Tajsic M, Járai R, Koch J, Stangl K, Wojta J, Dreger H, Huber K. Midregional pro-A-type natriuretic peptide as part of a dual biomarker strategy for the early rule out of non-ST segment elevation acute coronary syndrome - The WilCop study. Int J Cardiol. 2018;273:243-248. IF 3.471
  • Tscharre M, Herman R, Rohla M, Hauser C, Farhan S, Freynhofer MK, Huber K, Weiss TW. Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Atherosclerosis. 2018;270:173-179. IF 4.255

Publications ECP:

  • Schneider KH, Enayati M, Grasl C, Walter I, Budinsky L, Zebic G, Kaun C, Wagner A, Kratochwill K, Redl H, Teuschl AH, Podesser BK, Bergmeister H. Acellular vascular matrix grafts from human placenta chorion: Impact of ECM preservation on graft characteristics, protein composition and in vivo performance. Biomaterials. 2018;177:14-26. IF 10.273

Associated publications of the LBI for Cardiovascular Research 2018

Original papers and reviews on which PIs or project-associated co-workers appear as co-authors (highlighted in bold) are considered to be associated publications of the cluster and are listed below.

  • Aimo A, Januzzi J, Vergaro G, Ripoli A, Latini R, Masson S, Magnoli M, Anand I, Cohn J, Tavazzi L, Tognoni G, Gravning J, Ueland T, Nymo S, Brunner-LA Rocca H, Bayes-Genis A, Lupon J, de Boer R, Yoshihisa A, Yasuchika T, Egstrup M, Gustafsson I, Gaggin H, Eggers K, Huber K, Tentzeirs J, Tang WH, Grodin J, Passino C, Emdin M. Prognostic value of high-sensitivity troponin T in chronic heart failure. An individual patient data meta-analysis. Circulation. 2018;137:286-297. IF 23.054
  • Andreas M, Haberl T, Werner P, Guri J, Kocher A, Hamza O, Podesser B, Laufer G. Mitral valve repair with adjustable ring annuloplasty. Multimed Man Cardiothorac Surg. 2018;2018.
  • Bagai A, Goodman SG, Cantor WJ, Vicaut E, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Lapostolle F, Lassen JF, Merkely B, Storey RF, Ten Berg JM, Zeymer U, Diallo A, Hamm CW, Tsatsaris A, El Khoury J, Van't Hof AW, Montalescot G. Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC study. Am Heart J. 2018;196:56-64. IF 4.023
  • Benedetto U, Altman DG, Gerry S, Gray A, Lees B, Angelini GD, Flather M, Taggart DP; ART (Arterial Revascularization Trial) Investigators. Safety of perioperative aprotinin administration during isolated coronary artery bypass graft surgery: Insights from the ART (Arterial Revascularization Trial). J Am Heart Assoc. 2018;7. pii: e007570. IF 4.660
  • Benedetto U, Altman DG, Gerry S, Gray A, Lees B, Flather M, Taggart DP; Arterial Revascularization Trial investigators. Off-pump versus on-pump coronary artery bypass grafting: Insights from the Arterial Revascularization Trial. J Thorac Cardiovasc Surg. 2018 155:1545-1553. IF 5.261
  • Bonelli M, Puchner A, Göschl L, Hayer S, Niederreiter B, Steiner G, Tillmann K, Plasenzotti R, Podesser B, Georgel P, Smolen J, Scheinecker C, Blüml S. CCR6 controls autoimmune but not innate immunity-driven experimental arthritis. J Cell Mol Med. 2018;22:5278-5285. IF 4.658
  • Dew MA, DiMartini AF, Dobbels F, Grady KL, Jowsey-Gregoire SG, Kaan A, Kendall K, Young QR, Abbey SE, Butt Z, Crone CC, De Geest S, Doligalski CT, Kugler C, McDonald L, Ohler L, Painter L, Petty MG, Robson D, Schlöglhofer T, Schneekloth TD, Singer JP, Smith PJ, Spaderna H, Teuteberg JJ, Yusen RD, Zimbrean PC. The 2018 ISHLT/APM/AST/ICCAC/STSW Recommendations for the Psychosocial Evaluation of Adult Cardiothoracic Transplant Candidates and Candidates for Long-term Mechanical Circulatory Support. Psychosomatics. 2018;59:415-440. IF 1.541
  • Collet JP, Kerneis M, Lattuca B, Yan Y, Cayla G, Silvain J, Lapostolle F, Ecollan P, Diallo A, Vicaut E, Hamm CW, Van 't Hof AW, Montalescot G; ATLANTIC Investigators. Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysis. EuroIntervention. 2018;14:789-797. IF 4.018
  • Dew MA, DiMartini AF, Dobbels F, Grady KL, Jowsey-Gregoire SG, Kaan A, Kendall K, Young QR, Abbey SE, Butt Z, Crone CC, De Geest S, Doligalski CT, Kugler C, McDonald L, Ohler L, Painter L, Petty MG, Robson D, Schlöglhofer T, Schneekloth TD, Singer JP, Smith PJ, Spaderna H, Teuteberg JJ, Yusen RD, Zimbrean PC. The 2018 ISHLT/APM/AST/ICCAC/STSW recommendations for the psychosocial evaluation of adult cardiothoracic transplant candidates and candidates for long-term mechanical circulatory support. J Heart Lung Transplant. 2018;37:803-823. IF 8.578
  • Djinović Z, Pavelka R, Tomić M, Sprinzl G, Plenk H, Losert U, Bergmeister H, Plasenzotti R. In-vitro and in-vivo measurement of the animal's middle ear acoustical response by partially implantable fiber-optic sensing system. Biosens Bioelectron. 2018;103:176-181. IF 9.518
  • Goto S, Merrill P, Wallentin L, Wojdyla DM, Hanna M, Avezum A, Easton JD, Harjola VP, Huber K, Lewis BS, Parkhomenko A, Zhu J, Granger CB, Lopes RD, Alexander JH. Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE. Eur Heart J Cardiovasc Pharmacother. 2018;4:75-81. IF 6.723
  • Hinohara TT, Roe MT, White HD, Fox KAA, Bhatt DL, Hamm C, Gurbel PA, Aylward PE, Wiviott SD, Huber K, Neely ML, Ohman EM. Outcomes of patients receiving downstream revascularization after initial medical management for non-ST-segment elevation acute coronary syndromes (from the TRILOGY ACS trial). Am J Cardiol. 2018;122:1322-1329. IF 2.843
  • Kieler M, Unseld M, Wojta J, Kaider A, Bianconi D, Demyanets S, Prager GW. Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy. Med Oncol. 2018;36:1. IF 4.658
  • Königshofer P, Brusilovskaya K, Schwabl P, Podesser BK, Trauner M, Reiberger T. Invasive hemodynamic characterization of the portal-hypertensive syndrome in cirrhotic rats. J Vis Exp. 2018;(138) IF 1.108
  • Kopin D, Jones WS, Sherwood MW, Wojdyla DM, Wallentin L, Lewis BS, Verheugt FWA, Vinereanu D, Bahit MC, Halvorsen S, Huber K, Parkhomenko A, Granger CB, Lopes RD, Alexander JH. Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial. Am Heart J. 2018;197:133-141. IF 4.023
  • Mair J, Lindahl B, Hammarsten O, Müller C, Giannitsis E, Huber K, Möckel M, Plebani M, Thygesen K, Jaffe AS. How is cardiac troponin released from injured myocardium? Eur Heart J Acute Cardiovasc Care. 2018;7:553-560. IF 3.734
  • Mair J, Lindahl B, Müller C, Giannitsis E, Huber K, Möckel M, Plebani M, Thygesen K, Jaffe AS. What to do when you question cardiac troponin values. Eur Heart J Acute Cardiovasc Care. 2018;7:577-586. IF 3.734
  • Marschalek J, Wohlrab P, Ott J, Wojta J, Speidl W, Klein KU, Kiss H, Pateisky P, Zeisler H, Kuessel L. Maternal serum mitochondrial DNA (mtDNA) levels are elevated in preeclampsia - A matched case-control study. Pregnancy Hypertens. 2018;14:195-199. IF 3.252
  • Moayedifar R, Zuckermann A, Aliabadi-Zuckermann A, Riebandt J, Angleitner P, Dimitrov K, Schloeglhofer T, Rajek A, Laufer G, Zimpfer D. Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices. Eur J Cardiothorac Surg. 2018;54:1116-1121.
  • Mueller C, Möckel M, Giannitsis E, Huber K, Mair J, Plebani M, Thygesen K, Jaffe AS, Lindahl B; ESC Study Group on Biomarkers in Cardiology of the Acute Cardiovascular Care Association. Use of copeptin for rapid rule-out of acut myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2018;7:570-576. IF 3.734
  • Patti G, Pecen L, Lucerna M, Huber K, Rohla M, Renda G, Siller-Matula J, Schnabel RB, Cemin R, Kirchhof P, De Caterina R. Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries. Int J Cardiol. 2018;270:160-166. IF 3.471
  • Pentz R, Kaun C, Thaler B, Stojkovic S, Lenz M, Krychtiuk KA, Zuckermann A, Huber K, Wojta J, Hohensinner PJ, Demyanets S. Cardioprotective cytokine interleukin-33 is up-regulated by statins in human cardiac tissue. J Cell Mol Med. 2018 22:6122-6133. IF 4.658
  • Pol T, Held C, Westerbergh J, Lindbäck J, Alexander JH, Alings M, Erol C, Goto S, Halvorsen S, Huber K, Hanna M, Lopes RD, Ruzyllo W, Granger CB, Hijazi Z. Dyslipidemia and risk of cardiovascular events in patients with atrial fibrillation treated with oral anticoagulation therapy: insights from the ARISTOTLE (Apixaban for Reduction In STroke and Other ThromboemboLic Events in atrial fibrillation) trial. J Am Heart Assoc. 2018;7. pii: e007444. IF 4.660
  • Puchner A, Saferding V, Bonelli M, Mikami Y, Hofmann M, Brunner JS, Caldera M, Goncalves-Alves E, Binder NB, Fischer A, Simader E, Steiner CW, Leiss H, Hayer S, Niederreiter B, Karonitsch T, Koenders MI, Podesser BK, O'Shea JJ, Menche J, Smolen JS, Redlich K, Blüml S. Non-classical monocytes as mediators of tissue destruction in arthritis. Ann Rheum Dis. 2018;77:1490-1497. IF 14.299
  • Qi H, Soto-Gonzalez L, Krychtiuk KA, Ruhittel S, Kaun C, Speidl WS, Kiss A, Podesser BK, Yao S, Markstaller K, Klein KU, Tretter V. Pretreatment with argon protects human cardiac myocyte-like progenitor cells from oxygen glucose deprivation-induced cell death by activation of AKT and differential regulation of mapkinases. Shock. 2018;49:556-563. IF 3.083
  • Richter B, Sulzgruber P, Koller L, Steininger M, El-Hamid F, Rothgerber DJ, Forster S, Goliasch G, Silbert BI, Meyer EL, Hengstenberg C, Wojta J, Niessner A. Blood urea nitrogen has additive value beyond estimated glomerular filtration rate for prediction of long-term mortality in patients with acute myocardial infarction. Eur J Intern Med. 2019;59:84-90. IF 3.660
  • Riebandt J, Haberl T, Wiedemann D, Moayedifar R, Schloeglhofer T, Mahr S, Dimitrov K, Angleitner P, Laufer G, Zimpfer D. Extracorporeal membrane oxygenation support for right ventricular failure after left ventricular assist device implantation. Eur J Cardiothorac Surg. 2018;53:590-595.
  • Rocca B, Fox KAA, Ajjan RA, Andreotti F, Baigent C, Collet JP, Grove EL, Halvorsen S, Huber K, Morais J, Patrono C, Rubboli A, Seljeflot I, Sibbing D, Siegbahn A, Ten Berg J, Vilahur G, Verheugt FWA, Wallentin L, Weiss TW, Wojta J, Storey RF. Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis. Eur Heart J. 2018;39:1672-1686. IF 23.239
  • Rohla M, Tscharre M, Huber K, Weiss TW. Lowering blood pressure in primary care in Vienna (LOW-BP-VIENNA) : A cluster-randomized trial. Wien Klin Wochenschr. 2018;130:698-706. IF 1.170
  • Rohla M, Weiss TW, Pecen L, Patti G, Siller-Matula JM, Schnabel RB, Schilling R, Kotecha D, Lucerna M, Huber K, De Caterina R, Kirchhof P. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF). BMJ Open. 2019;9:e022478. IF 2.376
  • Sabatine MS, De Ferrari GM, Giugliano RP, Huber K, Lewis BS, Ferreira J, Kuder JF, Murphy SA, Wiviott SD, Kurtz CE, Honarpour N, Keech AC, Sever PS, Pedersen TR. Clinical benefit of evolocumab by severity and extent of coronary artery disease. Circulation. 2018;138:756-766. IF 23.054
  • Schettle S, Schlöglhofer T, Zimpfer D, Schima H, Kaufmann F, Salimbangon A, Wolforth J, Schroeder S, Hards R, Ritchie B, Staley L, Pereira N, Kushwaha S, Maltais S, Stulak J. International analysis of LVAD point-of-care versus plasma INR: A multicenter study. ASAIO J. 2018;64:e161-e165. IF 2.494
  • Schoergenhofer C, Schwameis M, Gelbenegger G, Buchtele N, Thaler B, Mussbacher M, Schabbauer G, Wojta J, Jilma-Stohlawetz P, Jilma B. Inhibition of protease-activated receptor (PAR1) reduces activation of the endothelium, coagulation, fibrinolysis and inflammation during human endotoxemia. Thromb Haemost. 2018;118:1176-1184. IF 4.733
  • Schwabl P, Brusilovskaya K, Supper P, Bauer D, Königshofer P, Riedl F, Hayden H, Fuchs CD, Stift J, Oberhuber G, Aschauer S, Bonderman D, Gnad T, Pfeifer A, Uschner FE, Trebicka J, Rohr-Udilova N, Podesser BK, Peck-Radosavljevic M, Trauner M, Reiberger T. The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats. Sci Rep. 2018;8:9372. IF 4.011
  • Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018;379:2097-2107. IF 70.670
  • Seidler K, Ehrmann K, Steinbauer P, Rohatschek A, Andriotis OG, Dworak C, Koch T, Bergmeister H, Grasl C, Schima H, Thurner P J, Liska R, Baudis S. A structural reconsideration: Linear aliphatic or alicyclic hard segments for biodegradable thermoplastic polyurethanes? J Polym Sci Part A Polym Chem. 2018;56:2214-2224.
  • Sibbing D, Gross L, Trenk D, Jacobshagen C, Geisler T, Hadamitzky M, Merkely B, Kiss RG, Komócsi A, Parma R, Felix SB, Neumann FJ, Hausleiter J, Baylacher M, Koltowski L, Mehilli J, Huber K, Huczek Z, Aradi D, Massberg S; TROPICAL-ACS Investigators. Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trial. Eur Heart J. 2018;39:2749-2758. IF 23.239
  • Siller-Matula JM, Pecen L, Patti G, Lucerna M, Kirchhof P, Lesiak M, Huber K, Verheugt FWA, Lang IM, Renda G, Schnabel RB, Wachter R, Kotecha D, Sellal JM, Rohla M, Ricci F, De Caterina R; TEAM in AF group. Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF – HF substudy. Int J Cardiol. 2018;265:141-147. IF 3.471
  • Steininger M, Winter MP, Reiberger T, Koller L, El-Hamid F, Forster S, Schnaubelt S, Hengstenberg C, Distelmaier K, Goliasch G, Wojta J, Toma A, Niessner A, Sulzgruber P. De-Ritis ratio improves long-term risk prediction after acute myocardial infarction. J Clin Med. 2018;7. pii: E474. IF 5.688
  • Stojkovic S, Jurisic M, Kopp CW, Koppensteiner R, Huber K, Wojta J, Gremmel T. Circulating microRNAs identify patients at increased risk of in-stent restenosis after peripheral angioplasty with stent implantation. Atherosclerosis. 2018;269:197-203. IF 4.255
  • Sulzgruber P, Thaler B, Koller L, Baumgartner J, Pilz A, Steininger M, Schnaubelt S, Fleck T, Laufer G, Steinlechner B, Winter MP, Goliasch G, Wojta J, Niessner A. CD4(+)CD28(null) T lymphocytes are associated with the development of atrial fibrillation after elective cardiac surgery. Sci Rep. 2018;8:9624. IF 4.011
  • Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, Eitel I, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Jobs A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Hunziker L, Savonitto S, Torremante P, Vrints C, Schneider S, Zeymer U, Desch S; CULPRIT-SHOCK Investigators. One-year outcomes after PCI strategies in cardiogenic shock. N Engl J Med. 2018;379:1699-1710. IF 70.670
  • Verheugt FWA, Gao H, Al Mahmeed W, Ambrosio G, Angchaisuksiri P, Atar D, Bassand JP, Camm AJ, Cools F, Eikelboom J, Kayani G, Lim TW, Misselwitz F, Pieper KS, van Eickels M, Kakkar AK; GARFIELD-AF Investigators. Characteristic patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry. Eur Heart J. 2018;39:464-473. IF 23.239
  • Vranckx P, Valgimigli M, Jüni P, Hamm C, Steg PG, Heg D, van Es GA, McFadden EP, Onuma Y, van Meijeren C, Chichareon P, Benit E, Möllmann H, Janssens L, Ferrario M, Moschovitis A, Zurakowski A, Dominici M, Van Geuns RJ, Huber K, Slagboom T, Serruys PW, Windecker S; GLOBAL LEADERS Investigators. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet. 2018;392:940-949. IF 59.102
  • Wiedemann D, Schlöglhofer T, Haberl T, Riebandt J, Dimitrov K, Schima H, Kastner J, Matzek W, Laufer G, Zimpfer D. Interventional treatment of LVAD outflow graft stenosis by introduction of bare metal stents. ASAIO J. 2018;64:e3-e7. IF 2.494
  • Winter MP, Wiesbauer F, Blessberger H, Pavo N, Sulzgruber P, Huber K, Wojta J, Distelmaier K, Lang IM, Goliasch G. Lipid profile and long-term outcome in premature myocardial infarction. Eur J Clin Invest. 2018;48:e13008. IF 2.748
  • Young C, Laufer G, Kocher A, Solinas M, Alamanni F, Polvani G, Podesser BK, Aramendi JI, Arribas J, Bouchot O, Livi U, Massetti M, Terp K, Giot C, Glauber M. One-year outcomes after rapid-deployment aortic valve replacement. J Thorac Cardiovasc Surg. 2018;155:575-585. IF 5.261
  • Zlabinger K, Lukovic D, Hemetsberger R, Gugerell A, Winkler J, Mandic L, Traxler D, Spannbauer A, Wolbank S, Zanoni G, Kaun C, Posa A, Gyenes A, Petrasi Z, Petnehazy Ö, Repa I, Hofer-Warbinek R, de Martin R, Gruber F, Charwat S, Huber K, Pavo N, Pavo IJ, Nyolczas N, Kraitchman DL, Gyöngyösi M. Matrix metalloproteinase-2 impairs homing of intracoronary delivered mesenchymal stem cells in a porcine reperfused myocardial infarction: comparison with intramyocardial cell delivery. Front Bioeng Biotechnol. 2018;6:35. IF 5.122

 

Publications of the LBC for Cardiovascular Research 2017

Only original papers or reviews on which either a PI or one of his/her co-workers associated with the respective project appear as first, last or corresponding author (highlighted in bold) are considered to be publications of the cluster.

Publications ASC:

  • Schima H. Welcome message - 44th ESAO and 7th IFAO Congress, 6-9 September 2017, Vienna, Austria. Int J Artif Organs. 2017 Aug 22;40(8):367. IF 1.169
  • Marko C, Xhelili E, Lackner T, Zimpfer D, Schima H, Moscato F. Exercise performance during the first two years after left ventricular assist device implantation. ASAIO J. 2017 Jul/Aug;63(4):408-413. IF 2.190

Publications INFO:

  • Hohensinner PJ, Baumgartner J, Kral-Pointner JB, Uhrin P, Ebenbauer B, Thaler B, Doberer K, Stojkovic S, Demyanets S, Fischer MB, Huber K, Schabbauer G, Speidl WS, Wojta J. PAI-1 (plasminogen activator inhibitor-1) expression renders alternatively activated human macrophages proteolytically quiescent. Arterioscler Thromb Vasc Biol. 2017 Oct;37(10):1913-1922. IF 6.607
  • Hohensinner PJ, Takacs N, Kaun C, Thaler B, Krychtiuk KA, Pfaffenberger S, Aliabadi A, Zuckermann A, Huber K, Wojta J. Urokinase plasminogen activator protects cardiac myocytes from oxidative damage and apoptosis via hOGG1 induction. Apoptosis. 2017 Aug;22(8):1048-1055. IF 3.833
  • Krychtiuk KA, Honeder MC, Lenz M, Maurer G, Wojta J, Heinz G, Huber K, Speidl WS. Copeptin Predicts Mortality in Critically Ill Patients. PLoS One. 2017 Jan 24;12(1):e0170436. IF 2.806
  • Krychtiuk KA, Kaun C, Hohensinner PJ, Stojkovic S, Seigner J, Kastl SP, Zuckermann A, Eppel W, Rauscher S, de Martin R, Maurer G, Huber K, Wojta J, Speidl WS. Anti-thrombotic and pro-fibrinolytic effects of levosimendan in human endothelial cells in vitro. Vascul Pharmacol. 2017 Mar;90:44-50. IF 3.718
  • Stojkovic S, Thulin Å, Hell L, Thaler B, Rauscher S, Baumgartner J, Gröger M, Ay C, Demyanets S, Neumayer C, Huk I, Spittler A, Huber K, Wojta J, Siegbahn A, Åberg M. IL-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets. Thromb Haemost. 2017 Jun 28;117(7):1379-1390. IF 5.627
  • Wojta J. What ADAMTS13 does in the liver…. Thromb Haemost. 2017 Jan 5;117(1):6. IF 5.627

Publications REM:

  • Kiss A, Tratsiakovich Y, Mahdi A, Yang J, Gonon AT, Podesser BK, Pernow J. Vagal nerve stimulation reduces infarct size via a mechanism involving the alpha-7 nicotinic acetylcholine receptor and downregulation of cardiac and vascular arginase. Acta Physiol (Oxf). 2017 Nov;221(3):174-181. IF 4.867
  • Trescher K, Gleiss A, Boxleitner M, Dietl W, Kassal H, Holzinger C, Podesser BK. Short-term clinical outcomes for intermittent cold versus intermittent warm blood cardioplegia in 2200 adult cardiac surgery patients. J Cardiovasc Surg (Torino). 2017 Feb;58(1):105-112. IF 2.179

Publications BIO:

  • Arfvidsson J, Ahlin F, Vargas KG, Thaler B, Wojta J, Huber K. Monocyte subsets in myocardial infarction: A review. Int J Cardiol. 2017 Mar 15;231:47-53. IF 6.189
  • Chan MY, Neely ML, Roe MT, Goodman SG, Erlinge D, Cornel JH, Winters KJ, Jakubowski JA, Zhou C, Fox KAA, Armstrong PW, White HD, Prabhakaran D, Ohman EM, Huber K; TRILOGY ACS Investigators. Temporal biomarker profiling reveals longitudinal changes in risk of death or myocardial infarction in non-ST-segment elevation acute coronary syndrome. Clin Chem. 2017 Jul;63(7):1214-1226. IF 8.008
  • Farhan S, Clare RM, Jarai R, Giugliano RP, Lokhnygina Y, Harrington RA, Kristin Newby L, Huber K. Fasting glucose, NT-proBNP, treatment with eptifibatide, and outcomes in non-ST-segment elevation acute coronary syndromes: An analysis from EARLY ACS. Int J Cardiol. 2017 Apr 1;232:264-270. IF 6.189
  • Freynhofer MK, Iliev L, Bruno V, Rohla M, Egger F, Weiss TW, Hübl W, Willheim M, Wojta J, Huber K. Platelet turnover predicts outcome after coronary intervention. Thromb Haemost. 2017 May 3;117(5):923-933. IF 5.627
  • Haller PM, Kiss A, Wojta J, Podesser BK, Huber K. [Cardioprotection via the arm?: How a blood pressure cuff decreases infarct sizes]. Herz. 2017 Sep;42(6):565-572. IF 0.776
  • Halvorsen S, Storey RF, Rocca B, Sibbing D, Ten Berg J, Grove EL, Weiss TW, Collet JP, Andreotti F, Gulba DC, Lip GYH, Husted S, Vilahur G, Morais J, Verheugt FWA, Lanas A, Al-Shahi Salman R, Steg PG, Huber K; ESC Working Group on Thrombosis. Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J. 2017 May 14;38(19):1455-1462. IF 20.212
  • Huber K, Verheugt FW. Bivalirudin in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: uncertainties almost clarified. EuroIntervention. 2017 Mar 20;12(16):1930-1932. IF 5.193
  • Huber K, Ducrocq G, Hamm CW, van 't Hof A, Lapostolle F, Coste P, Gordini G, Steinmetz J, Verheugt FWA, Adgey J, Nibbe L, Kaniĉ V, Clemmensen P, Zeymer U, Bernstein D, Prats J, Deliargyris EN, Gabriel Steg P. Early clinical outcomes as a function of use of newer oral P2Y(12) inhibitors versus clopidogrel in the EUROMAX trial. Open Heart. 2017 Nov 28;4(2):e000677.
  • Jäger B, Farhan S, Rohla M, Christ G, Podczeck-Schweighofer A, Schreiber W, Laggner AN, Weidinger F, Stefenelli T, Delle-Karth G, Kaff A, Maurer G, Huber K; Vienna STEMI Registry Group. Clinical predictors of patient related delay in the VIENNA ST-elevation myocardial infarction network and impact on long-term mortality. Eur Heart J Acute Cardiovasc Care. 2017 Apr;6(3):254-261.
  • Piackova E, Jäger B, Farhan S, Christ G, Schreiber W, Weidinger F, Stefenelli T, Delle-Karth G, Kaff A, Maurer G, Huber K; Vienna STEMI Registry Group. Gender differences in short- and long-term mortality in the Vienna STEMI registry. Int J Cardiol. 2017 Oct 1;244:303-308.
  • Sibbing D, Angiolillo DJ, Huber K. Antithrombotic therapy for acute coronary syndrome: Past, present and future. Thromb Haemost. 2017 Jun 28;117(7):1240-1248. IF 5.627
  • Tentzeris I, Farhan S, Freynhofer MK, Rohla M, Jarai R, Vogel B, Baumgartner-Parzer S, Nürnberg M, Geppert A, Wessely E, Wojta J, Huber K, Kautzky-Willer A. Usefulness of elevated levels of growth differentiation factor-15 to classify patients with acute coronary syndrome having percutaneous coronary intervention who would benefit from high-dose statin therapy. Am J Cardiol. 2017 Sep 1;120(5):747-752. IF 3.398
  • Tscharre M, Jäger B, Farhan S, Christ G, Schreiber W, Weidinger F, Stefenelli T, Delle-Karth G, Kaff A, Maurer G, Huber K; Vienna STEMI Registry Group. Impact of time of admission on short- and long-term mortality in the Vienna STEMI registry. Int J Cardiol. 2017 Oct 1;244:1-6. IF 6.189
  • Tscharre M, Hauser C, Rohla M, Freynhofer MK, Wojta J, Huber K, Weiss TW. Epicardial adipose tissue and cardiovascular outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2017 Dec;6(8):750-752.
  • Tscharre M, Egger F, Machata M, Rohla M, Michael N, Neumayr M, Zweiker R, Hajos J, Adlbrecht C, Suppan M, Helmreich W, Eber B, Huber K, Weiss TW. Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry. PLoS One. 2017 Jun 20;12(6):e0179349. IF 2.806

 

Associated publications of the LBC for Cardiovascular Research 2017

Original papers and reviews on which PIs or project-associated co-workers appear as co-authors (highlighted in bold) are considered to be associated publications of the cluster and are listed below.

 

  • Aass T, Stangeland L, Chambers DJ, Hallström S, Rossmann C, Podesser BK, Urban M, Nesheim K, Haaverstad R, Matre K, Grong K. Myocardial energy metabolism and ultrastructure with polarizing and depolarizing cardioplegia in a porcine model. Eur J Cardiothorac Surg. 2017 Jul 1;52(1):180-188. IF 3.759
  • Alfonso F; Editors' Network European Society of Cardiology Task Forc; Editors' Network European Society of Cardiology Task Force. Data sharing. Eur Heart J. 2017 May 7;38(18):1361-1363. IF 20.212
  • Alfonso F, Adamyan K, Artigou JY, Aschermann M, Boehm M, Buendia A, Chu PH, Cohen A, Dei Cas L, Dilic M, Doubell A, Echeverri D, Enç N, Ferreira-González I, Filipiak KJ, Flammer A, Fleck E, Gatzov P, Ginghina C, Goncalves L, Haouala H, Hassanein M, Heusch G, Huber K, Hulín I, Ivanusa M, Krittayaphong R, Lau CP, Marinskis G, Mach F, Felipe Moreira L, Nieminen T, Oukerraj L, Perings S, Pierard L, Potpara T, Reyes-Caorsi W, Rim SJ, Rødevand O, Saade G, Sander M, Shlyakhto E, Timuralp B, Tousoulis D, Ural D, Piek JJ, Varga A, Lüscher TF; Editors' Network European Society of Cardiology Task Force. Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors. Implications for the editors' network. Egypt Heart J. 2017 Jun;69(2):89-94.
  • Alfonso F, Adamyan K, Artigou JY, Aschermann M, Boehm M, Buendia A, Chu PH, Cohen A, Cas LD, Dilic M, Doubell A, Echeverri D, Enç N, Ferreira-González I, Filipiak KJ, Flammer A, Fleck E, Gatzov P, Ginghina C, Goncalves L, Haouala H, Hassanein M, Heusch G, Huber K, Hulín I, Ivanusa M, Krittayaphong R, Lau CP, Marinskis G, Mach F, Moreira LF, Nieminen T, Oukerraj L, Perings S, Pierard L, Potpara T, Reyes-Caorsi W, Rim SJ, Rødevand O, Saade G, Sander M, Shlyakhto E, Timuralp B, Tousoulis D, Ural D, Piek JJ, Varga A, Lüscher TF. Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors. Implications for the editors' network. Turk Kardiyol Dern Ars. 2017 Jun;45(4):377-384.
  • Alfonso F, Adamyan K, Artigou JY, Aschermann M, Boehm M, Buendia A, Chu PH, Cohen A, Cas LD, Dilic M, Doubell A, Echeverri D, Enç N, Ferreira-González I, Filipiak KJ, Flammer A, Fleck E, Gatzov P, Ginghina C, Goncalves L, Haouala H, Hassanein M, Heusch G, Huber K, Hulín I, Ivanusa M, Krittayaphong R, Lau CP, Marinskis G, Mach F, Moreira LF, Nieminen T, Oukerraj L, Perings S, Pierard L, Potpara T, Reyes-Caorsi W, Rim SJ, Rødevand O, Saade G, Sander M, Shlyakhto E, Timuralp B, Tousoulis D, Ural D, Piek JJ, Varga A, Lüscher TF. Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors. Implications for the editors' network. Acta Cardiol Sin. 2017 May;33(3):315-322. IF 0.342
  • Alfonso F, Adamyan K, Artigou JY, Aschermann M, Boehm M, Buendia A, Chu PH, Cohen A, Cas LD, Dilic M, Doubell A, Echeverri D, Enç N, Ferreira-González I, Filipiak KJ, Flammer A, Fleck E, Gatzov P, Ginghina C, Goncalves L, Haouala H, Hassanein M, Heusch G, Huber K, Hulín I, Ivanusa M, Krittayaphong R, Lau CP, Marinskis G, Mach F, Moreira LF, Nieminen T, Oukerraj L, Perings S, Pierard L, Potpara T, Reyes-Caorsi W, Rim SJ, Rødevand O, Saade G, Sander M, Shlyakhto E, Timuralp B, Tousoulis D, Ural D, Piek JJ, Varga A, Lüscher TF. Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors. Implications for the editors' network. Arch Cardiol Mex. 2017 Apr - Jun;87(2):101-107.
  • Alfonso F, Adamyan K, Artigou JY, Aschermann M, Boehm M, Buendia A, Chu PH, Cohen A, Cas LD, Dilic M, Doubell A, Echeverri D, Enç N, Ferreira-González I, Filipiak KJ, Flammer A, Fleck E, Gatzov P, Ginghina C, Goncalves L, Haouala H, Hassanein M, Heusch G, Huber K, Hulín I, Ivanusa M, Krittayaphong R, Lau CP, Marinskis G, Mach F, Moreira LF, Nieminen T, Oukerraj L, Perings S, Pierard L, Potpara T, Reyes-Caorsi W, Rim SJ, Rødevand O, Saade G, Sander M, Shlyakhto E, Timuralp B, Tousoulis D, Ural D, Piek JJ, Varga A, Lüscher TF. Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors. Implications for the editors' network. Arq Bras Cardiol. 2017 May;108(5):390-395. IF 1.186
  • Alfonso F, Adamyan K, Artigou JY, Aschermann M, Boehm M, Buendia A, Chu PH, Cohen A, Cas LD, Dilic M, Doubell A, Echeverri D, Enç N, Ferreira-González I, Filipiak KJ, Flammer A, Fleck E, Gatzov P, Ginghina C, Goncalves L, Haouala H, Hassanein M, Heusch G, Huber K, Hulín I, Ivanusa M, Krittayaphong R, Lau CP, Marinskis G, Mach F, Moreira LF, Nieminen T, Oukerraj L, Perings S, Pierard L, Potpara T, Reyes-Caorsi W, Rim SJ, Rødevand O, Saade G, Sander M, Shlyakhto E, Timuralp B, Tousoulis D, Ural D, Piek JJ, Varga A, Lüscher TF. Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors. Implications for the editors' network. Kardiol Pol. 2017;75(5):512-517. IF 1.341
  • Andreas M, Moayedifar R, Wieselthaler G, Wolzt M, Riebandt J, Haberl T, Angleitner P, Schlöglhofer T, Wiedemann D, Schima H, Laufer G, Zimpfer D. Increased thromboembolic events with dabigatran compared with vitamin K antagonism in left ventricular assist device patients: A randomized controlled pilot trial. Circ Heart Fail. 2017 May;10(5). pii: e00370 IF 6.372
  • Auer J, Huber K, Granger CB. Interruption of non-vitamin K antagonist anticoagulants in patients undergoing planned invasive procedures: how long is long enough? Eur Heart J. 2017 Aug 14;38(31):2440-2443. IF 20.212
  • Bagai A, Goodman SG, Cantor WJ, Vicaut E, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Lapostolle F, Lassen JF, Merkely B, Storey RF, Ten Berg JM, Zeymer U, Diallo A, Hamm CW, Tsatsaris A, El Khoury J, Van't Hof AW, Montalescot G. Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC study. Am Heart J. 2018 Feb;196:56-64. IF 4.436
  • Beygui F, Castren M, Brunetti ND, Rosell-Ortiz F, Christ M, Zeymer U, Huber K, Folke F, Svensson L, Bueno H, Van't Hof A, Nikolaou N, Nibbe L, Charpentier S, Swahn E, Tubaro M, Goldstein P. [Pre-hospital management of patients with chest pain and/or dyspnoea of cardiac origin. ]. Recenti Prog Med. 2017 Jan;108(1):27-51.
  • Djinović Z, Pavelka R, Tomić M, Sprinzl G, Plenk H, Losert U, Bergmeister H, Plasenzotti R. In-vitro and in-vivo measurement of the animal's middle ear acoustical response by partially implantable fiber-optic sensing system. Biosens Bioelectron. 2018 Apr 30;103:176-181. IF 7.780
  • Eilenberg W, Stojkovic S, Kaider A, Kozakowski N, Domenig CM, Burghuber C, Nanobachvili J, Huber K, Klinger M, Neumayer C, Huk I, Wojta J, Demyanets S. NGAL and MMP-9/NGAL as biomarkers of plaque vulnerability and targets of statins in patients with carotid atherosclerosis. Clin Chem Lab Med. 2017 Nov 27;56(1):147-156. IF 3.432
  • Eilenberg W, Stojkovic S, Piechota-Polanczyk A, Kaider A, Kozakowski N, Weninger WJ, Nanobachvili J, Wojta J, Huk I, Demyanets S, Neumayer C. Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment. Cardiovasc Diabetol. 2017 Aug 8;16(1):98. IF 4.752
  • Fabris E, Van't Hof A, Hamm CW, Lapostolle F, Lassen JF, Goodman SG, Ten Berg JM, Bolognese L, Cequier A, Chettibi M, Hammett CH, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Cantor WJ, Rousseau H, Vicaut E, Montalescot G. Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial. EuroIntervention. 2017 May 15;13(1):69-77. IF 5.193
  • Fellner B, Rohla M, Jarai R, Smetana P, Freynhofer MK, Egger F, Zorn G, Weiss TW, Huber K, Geppert A. Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2017 Jun;6(4):348-358.
  • Giannitsis E, Mair J, Christersson C, Siegbahn A, Huber K, Jaffe AS, Peacock WF, Plebani M, Thygesen K, Möckel M, Mueller C, Lindahl B; Biomarker Study Group of the European Society of Cardiology (ESC) Acute Cardiovascular Care Association (ACCA). How to use D-dimer in acute cardiovascular care. Eur Heart J Acute Cardiovasc Care. 2017 Feb;6(1):69-80.
  • Giugliano RP, Keech A, Murphy SA, Huber K, Tokgozoglu SL, Lewis BS, Ferreira J, Pineda AL, Somaratne R, Sever PS, Pedersen TR, Sabatine MS. Clinical efficacy and safety of evolocumab in high-risk patients receiving a statin: Secondary analysis of patients with low LDL cholesterol levels and in those already receiving a maximal-potency statin in a randomized clinical trial. JAMA Cardiol. 2017 Dec 1;2(12):1385-1391.
  • Hadzijusufovic E, Albrecht-Schgoer K, Huber K, Hoermann G, Grebien F, Eisenwort G, Schgoer W, Herndlhofer S, Kaun C, Theurl M, Sperr WR, Rix U, Sadovnik I, Jilma B, Schernthaner GH, Wojta J, Wolf D, Superti-Furga G, Kirchmair R, Valent P. Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site. Leukemia. 2017 Nov;31(11):2388-2397. IF 11.702
  • Hafner C, Wu J, Soto-Gonzalez L, Kaun C, Stojkovic S, Wojta J, Tretter V, Markstaller K, Klein KU. Moderate hyperoxia induces inflammation, apoptosis and necrosis in human umbilical vein endothelial cells: An in-vitro study. Eur J Anaesthesiol. 2017 Mar;34(3):141-149. IF 3.570
  • Hafner C, Wu J, Tiboldi A, Hess M, Mitulovic G, Kaun C, Krychtiuk KA, Wojta J, Ullrich R, Tretter EV, Markstaller K, Klein KU. Hyperoxia induces inflammation and cytotoxicity in human adult cardiac myocytes. Shock. 2017 Apr;47(4):436-444. IF 3.113
  • Hasun M, Dörler J, Edlinger M, Alber H, Von Lewinski D, Eber B, Roithinger FX, Berger R, Siostrzonek P, Grimm G, Benzer W, Wintersteller W, Huber K, Schuchlenz H, Weidinger F; Austrian Acute PCI Investigators. In-hospital outcome comparing bivalirudin to heparin in real-world primary percutaneous coronary intervention. Am J Cardiol. 2017 Dec 15;120(12):2135-2140. IF 3.398
  • Herta J, Wang WT, Höftberger R, Breit S, Kneissl S, Bergmeister H, Ferraz-Leite H. An experimental animal model for percutaneous procedures used in trigeminal neuralgia. Acta Neurochir (Wien). 2017 Jul;159(7):1341-1348. IF 1.881
  • Holnthoner W, Bonstingl C, Hromada C, Muehleder S, Zipperle J, Stojkovic S, Redl H, Wojta J, Schöchl H, Grillari J, Weilner S, Schlimp CJ. Endothelial cell-derived extracellular vesicles size-dependently exert procoagulant activity detected by thromboelastometry. Sci Rep. 2017 Jun 16;7(1):3707. IF 4.259
  • Koller L, Richter B, Winter MP, Sulzgruber P, Potolidis C, Liebhart F, Mörtl D, Berger R, Goliasch G, Lang I, Wojta J, Hülsmann M, Niessner A. Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failure. J Clin Lipidol. 2017 Jan - Feb;11(1):178-184. IF 5.812
  • Koller L, Stojkovic S, Richter B, Sulzgruber P, Potolidis C, Liebhart F, Mörtl D, Berger R, Goliasch G, Wojta J, Hülsmann M, Niessner A. Soluble urokinase-type plasminogen activator receptor improves risk prediction in patients with chronic heart failure. JACC Heart Fail. 2017 Apr;5(4):268-277. IF 8.493
  • Kopin D, Jones WS, Sherwood MW, Wojdyla DM, Wallentin L, Lewis BS, Verheugt FWA, Vinereanu D, Bahit MC, Halvorsen S, Huber K, Parkhomenko A, Granger CB, Lopes RD, Alexander JH. Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial. Am Heart J. 2018 Mar;197:133-141. IF 4.436
  • Leiss H, Salzberger W, Jacobs B, Gessl I, Kozakowski N, Blüml S, Puchner A, Kiss A, Podesser BK, Smolen JS, Stummvoll GH. MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupus. PLoS One. 2017 Jul 18;12(7):e0181015. IF 2.806
  • Liu Z, Silvain J, Kerneis M, Barthélémy O, Payot L, Choussat R, Sabouret P, Cohen M, Pollack CV Jr, Goldstein P, Zeymer U, Huber K, Vicaut E, Collet JP, Montalescot G. Intravenous enoxaparin versus unfractionated heparin in elderly patients undergoing primary percutaneous coronary intervention: An analysis of the randomized ATOLL trial. Angiology. 2017 Jan;68(1):29-39. IF 3.085
  • Lowenstern A, Storey RF, Neely M, Sun JL, Angiolillo DJ, Cannon CP, Himmelmann A, Huber K, James SK, Katus HA, Morais J, Siegbahn A, Steg PG, Wallentin L, Becker RC; PLATO Investigators. Platelet-related biomarkers and their response to inhibition with aspirin and p2y(12)-receptor antagonists in patients with acute coronary syndrome. J Thromb Thrombolysis. 2017 Aug;44(2):145-153. IF 2.142
  • Macfelda K, Kapeller B, Holly A, Podesser BK, Losert U, Brandes K, Goettel P, Mueller J. Bioelectrical signals improve cardiac function and modify gene expression of extracellular matrix components. ESC Heart Fail. 2017 Aug;4(3):291-300.
  • Mair J, Lindahl B, Giannitsis E, Huber K, Thygesen K, Plebani M, Möckel M, Müller C, Jaffe AS; Biomarker Study Group of the European Society of Cardiology Acute Cardiovascular Care Association. Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care? Eur Heart J Acute Cardiovasc Care. 2017 Jun;6(4):321-328.
  • Möckel M, Giannitsis E, Mueller C, Huber K, Jaffe AS, Mair J, Plebani M, Thygesen K, Lindahl B; Biomarker Study Group of the European Society of Cardiology Acute Cardiovascular Care Association. Editor's Choice-Rule-in of acute myocardial infarction: Focus on troponin. Eur Heart J Acute Cardiovasc Care. 2017 Apr;6(3):212-217.
  • Mueller C, Giannitsis E, Möckel M, Huber K, Mair J, Plebani M, Thygesen K, Jaffe AS, Lindahl B; Biomarker Study Group of the ESC Acute Cardiovascular Care Association. Rapid rule out of acute myocardial infarction: novel biomarker-based strategies. Eur Heart J Acute Cardiovasc Care. 2017 Apr;6(3):218-222.
  • Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, Horton RP, Buchbinder M, Neuzil P, Gordon NT, Holmes DR Jr.; PREVAIL and PROTECT AF Investigators. 5-year outcomes after left atrial appendage closure: From the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017 Dec 19;70(24):2964-2975. IF 19.896
  • Rubboli A, Agewall S, Huber K, Lip GYH. New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose. Eur J Intern Med. 2017 May;40:e11-e12. IF 2.960
  • Schiele F, Gale CP, Bonnefoy E, Capuano F, Claeys MJ, Danchin N, Fox KA, Huber K, Iakobishvili Z, Lettino M, Quinn T, Rubini Gimenez M, Bøtker HE, Swahn E, Timmis A, Tubaro M, Vrints C, Walker D, Zahger D, Zeymer U, Bueno H. Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care. 2017 Feb;6(1):34-59.
  • Schreiber C, Eilenberg M, Kiss A, Bergmeister H, Podesser B, Mascherbauer J, Bonderman D. Preserved right ventricular integrity in a new telemetric rat model of severe pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2017 Nov 1;313(5):L957-L963. IF 4.281
  • Schreiber C, Eilenberg MS, Panzenboeck A, Winter MP, Bergmeister H, Herzog R, Mascherbauer J, Lang IM, Bonderman D. Combined oral administration of L-arginine and tetrahydrobiopterin in a rat model of pulmonary arterial hypertension. Pulm Circ. 2017 Apr 4;7(1):89-97. IF 2.178
  • Schwabl P, Hambruch E, Seeland BA, Hayden H, Wagner M, Garnys L, Strobel B, Schubert TL, Riedl F, Mitteregger D, Burnet M, Starlinger P, Oberhuber G, Deuschle U, Rohr-Udilova N, Podesser BK, Peck-Radosavljevic M, Reiberger T, Kremoser C, Trauner M. The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction. J Hepatol. 2017 Apr;66(4):724-733. IF 12.486
  • Sibbing D, Aradi D, Jacobshagen C, Gross L, Trenk D, Geisler T, Orban M, Gori T, Hadamitzky M, Merkely B, Kiss RG, Komócsi A, Dézsi CA, Thalmeier A, Löw A, Holdt L, Teupser D, Ince H, Felix SB, Parma R, Malek L, Horstkotte J, Baylacher M, Schwinger R, Rieber J, Mudra H, Hausleiter J, Huber K, Neumann FJ, Koltowski L, Huczek Z, Mehilli J, Massberg S; TROPICAL-ACS Investigators. A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial. Thromb Haemost. 2017 Jan 5;117(1):188-195. IF 5.627
  • Sibbing D, Aradi D, Jacobshagen C, Gross L, Trenk D, Geisler T, Orban M, Hadamitzky M, Merkely B, Kiss RG, Komócsi A, Dézsi CA, Holdt L, Felix SB, Parma R, Klopotowski M, Schwinger RHG, Rieber J, Huber K, Neumann FJ, Koltowski L, Mehilli J, Huczek Z, Massberg S; TROPICAL-ACS Investigators. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial. Lancet. 2017 Oct 14;390(10104):1747-1757. IF 47.831
  • Siller-Matula JM, Petre A, Delle-Karth G, Huber K, Ay C, Lordkipanidzé M, De Caterina R, Kolh P, Mahla E, Gersh BJ. Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: A systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care. 2017 Dec;6(8):753-770.
  • Stanetic BM, Ostojic M, Campos CM, Marinkovic J, Farooq V, Kovacevic-Preradovic T, Huber K, Serruys PW. ApPropriateness of myocardial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study. Int J Cardiol. 2017 Jan 15;227:478-484. IF 6.189
  • Sulzgruber P, El-Hamid F, Koller L, Forster S, Goliasch G, Wojta J, Niessner A. Long-term outcome and risk prediction in patients suffering acute myocardial infarction complicated by post-infarction cardiac rupture. Int J Cardiol. 2017 Jan 15;227:399-403. IF 6.189
  • Sulzgruber P, Koller L, Winter MP, Richter B, Blum S, Korpak M, Hülsmann M, Goliasch G, Wojta J, Niessner A. The impact of CD4(+)CD28(null) T-lymphocytes on atrial fibrillation and mortality in patients with chronic heart failure. Thromb Haemost. 2017 Jan 26;117(2):349-356. IF 5.627
  • Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Savonitto S, Torremante P, Vrints C, Schneider S, Desch S, Zeymer U; CULPRIT-SHOCK Investigators. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017 Dec 21;377(25):2419-2432. IF 72.406
  • Wiedemann D, Schlöglhofer T, Riebandt J, Neuner M, Tschernko E, Schima H, Zimpfer D. From research lab to clinical routine of MCS. ASAIO J. 2017 Jul/Aug;63(4):e51. IF 2.190
  • Wiedemann D, Schlöglhofer T, Riebandt J, Neuner M, Tschernko E, Schima H, Zimpfer D. Myocardial recovery in peripartum cardiomyopathy after hyperprolactinemia treatment on BIVAD. ASAIO J. 2017 Jan/Feb;63(1):109-111. IF 2.190
  • Wilflingseder J, Jelencsics K, Bergmeister H, Sunzenauer J, Regele H, Eskandary F, Reindl-Schwaighofer R, Kainz A, Oberbauer R. miR-182-5p inhibition ameliorates ischemic acute kidney injury. Am J Pathol. 2017 Jan;187(1):70-79. IF 4.057
  • Winter MP, Blessberger H, Alimohammadi A, Pavo N, Huber K, Wojta J, Lang IM, Wiesbauer F, Goliasch G. Long-term outcome and risk assessment in premature acute myocardial infarction: A 10-year follow-up study. Int J Cardiol. 2017 Aug 1;240:37-42. IF 6.189
  • Young C, Laufer G, Kocher A, Solinas M, Alamanni F, Polvani G, Podesser BK, Aramendi JI, Arribas J, Bouchot O, Livi U, Massetti M, Terp K, Giot C, Glauber M. One-year outcomes after rapid-deployment aortic valve replacement. J Thorac Cardiovasc Surg. 2018 Feb;155(2):575-585. IF 4.446

Publications of the LBC for Cardiovascular Research 2016

Only original papers or reviews on which either a PI or one of his/her co-workers associated with the respective project appear as first, last or corresponding author (highlighted in bold) are considered to be publications of the cluster.

Publications ASC:

  • Granegger M, Aigner P, Haberl T, Mahr S, Tamez DA, Graham J, Nunez NJ, Schima H, Moscato F. Interaction of a transapical miniaturized ventricular assist device with the left ventricle: hemodynamic evaluation and visualization in an isolated heart setup. Artif Organs. 2016 Dec;40(12):1113-1120. IF 1.993
  • Granegger M, Masetti M, Laohasurayodhin R, Schloeglhofer T, Zimpfer D, Schima H, Moscato F. Continuous monitoring of aortic valve opening in rotary blood pump patients. IEEE Trans Biomed Eng. 2016 Jun;63(6):1201-7. IF 2.468
  • Granegger M, Schlöglhofer T, Ober H, Zimpfer D, Schima H, Moscato F. Daily life activity in patients with left ventricular assist devices. Int J Artif Organs. 2016 Jan;39(1):22-7. IF 1.008
  • Moscato F, Gross C, Haller M, Marko C, Zimpfer D, Schima H. Track H. Cardio technology. Biomed Tech (Berl). 2016 Sep 1;61(s1):70-80.
  • Schima H, Dimitrov K, Zimpfer D. Debate: creating adequate pulse with a continuous flow ventricular assist device: can it be done and should it be done? Probably not, it may cause more problems than benefits! Curr Opin Cardiol. 2016 May;31(3):337-42. IF 2.158
  • Zimpfer D, Strueber M, Aigner P, Schmitto JD, Fiane AE, Larbalestier R, Tsui S, Jansz P, Simon A, Schueler S, Moscato F, Schima H. Evaluation of the HeartWare ventricular assist device Lavare cycle in a particle image velocimetry model and in clinical practice. Eur J Cardiothorac Surg. 2016 Nov;50(5):839-848. IF 2.803

Publications INFO:

  • Ahlin F, Arfvidsson J, Vargas KG, Stojkovic S, Huber K, Wojta J. MicroRNAs as circulating biomarkers in acute coronary syndromes: A review. Vascul Pharmacol. 2016 Jun;81:15-21. IF 2.500
  • Gyöngyösi M. Is increased homocysteine level a false trail or an accomplice to saphenous venous graft degeneration? Anatol J Cardiol. 2016 Nov;16(11):874. IF 1.414
  • Gyöngyösi M, Giurgea GA, Syeda B, Charwat S, Marzluf B, Mascherbauer J, Jakab A, Zimba A, Sárközy M, Pavo N, Sochor H, Graf S, Lang I, Maurer G, Bergler-Klein J; MYSTAR investigators.. Long-term outcome of combined (percutaneous intramyocardial and intracoronary) application of autologous bone marrow mononuclear cells post myocardial infarction: The 5-Year MYSTAR Study. PLoS One. 2016 Oct 20;11(10):e0164908 IF 3.057
  • Gyöngyösi M, Wojakowski W, Navarese EP, Moye LÀ; ACCRUE Investigators.. Meta-analyses of human cell-based cardiac regeneration therapies: Controversies
  • in meta-analyses results on cardiac cell-based regenerative studies. Circ Res. 2016 Apr 15;118(8):1254-63. IF 11.551
  • Hohensinner PJ, Ebenbauer B, Kaun C, Maurer G, Huber K, Wojta J. Reduced Ang2 expression in aging endothelial cells. Biochem Biophys Res Commun. 2016 Jun 3;474(3):447-51. IF 2.371
  • Hohensinner PJ, Kaun C, Buchberger E, Ebenbauer B, Demyanets S, Huk I, Eppel W, Maurer G, Huber K, Wojta J. Age intrinsic loss of telomere protection via TRF1 reduction in endothelial cells. Biochim Biophys Acta. 2016 Feb;1863(2):360-7. IF 5.128
  • Krychtiuk KA, Lenz M, Koller L, Honeder MC, Wutzlhofer L, Zhang C, Chi L, Maurer G, Niessner A, Huber K, Wojta J, Heinz G, Speidl WS. Monocyte subset distribution is associated with mortality in critically ill patients. Thromb Haemost. 2016 Oct 28;116(5):949-957. IF 5.255
  • Mandic L, Traxler D, Gugerell A, Zlabinger K, Lukovic D, Pavo N, Goliasch G, Spannbauer A, Winkler J, Gyöngyösi M. Molecular imaging of angiogenesis in cardiac regeneration. Curr Cardiovasc Imaging Rep. 2016;9(10):27.
  • Montanari E, Stojkovic S, Kaun C, Lemberger CE, de Martin R, Rauscher S, Gröger M, Maurer G, Neumayer C, Huk I, Huber K, Demyanets S, Wojta J. Interleukin-33 stimulates GM-CSF and M-CSF production by human endothelial cells. Thromb Haemost. 2016 Aug 1;116(2):317-27. IF 5.255
  • Pavo N, Wurm R, Goliasch G, Novak JF, Strunk G, Gyöngyösi M, Poglitsch M, Säemann MD, Hülsmann M. Renin-angiotensin system fingerprints of heart failure with reduced ejection fraction. J Am Coll Cardiol. 2016 Dec 27;68(25):2912-2914. IF 17.759
  • Pavo N, Samaha E, Sabdyusheva I, von Strandmann RP, Stahnke S, Plass CA, Zlabinger K, Lukovic D, Jambrik Z, Pavo IJ, Bergler-Klein J, Gray WA, Maurer G, Gyöngyösi M. Coating of intravascular balloon with paclitaxel prevents constrictive remodeling of the dilated porcine femoral artery due to inhibition of intimal and media fibrosis. J Mater Sci Mater Med. 2016 Aug;27(8):131. IF 2.272
  • Stojkovic S, Kaun C, Basilio J, Rauscher S, Hell L, Krychtiuk KA, Bonstingl C, de Martin R, Gröger M, Ay C, Holnthoner W, Eppel W, Neumayer C, Huk I, Huber K, Demyanets S, Wojta J. Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation. Sci Rep. 2016 May 4;6:25171. IF 5.228
  • Thaler B, Hohensinner PJ, Krychtiuk KA, Matzneller P, Koller L, Brekalo M, Maurer G, Huber K, Zeitlinger M, Jilma B, Wojta J, Speidl WS. Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans. Sci Rep. 2016 Jul 22;6:30162. IF 5.228
  • Wojta J. Cenderitide: a multivalent designer-peptide-agonist of particulate guanylyl cyclase receptors with considerable therapeutic potential in cardiorenal disease states. Eur Heart J Cardiovasc Pharmacother. 2016 Apr;2(2):106-7.

Publications REM:

  • Bergmeister K, Podesser B. Acceptance of animal research in our science community. Version 2. F1000Res. 2016 Mar 4 [revised 2016 Jul 8];5:282.
  • Kremer J, Muschitz GK, Aumayr K, Moser P, Szabo G, Weymann A, Zuckermann A, Podesser BK. Influence of antithymocyte globulin treatment of brain-dead organ donor on inflammatory response in cardiac grafts: an experimental study in mice. Transpl Int. 2016 Dec;29(12):1329-1336. IF 2.835
  • Taggart DP, Altman DG, Gray AM, Lees B, Gerry S, Benedetto U, Flather M; ART Investigators.. Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts. N Engl J Med. 2016 Dec 29;375(26):2540-9. IF 59.558

Publications BIO:

  • Farhan S, Vogel B, Tentzeris I, Jarai R, Freynhofer MK, Smetana P, Egger F, Kautzky-Willer A, Huber K. Contrast induced acute kidney injury in acute coronary syndrome patients: A single centre experience. Eur Heart J Acute Cardiovasc Care. 2016 Feb;5(1):55-61.
  • Haller PM, Kiss A, Wojta J, Podesser BK, Huber K. [Cardioprotection via the arm?: How a blood pressure cuff decreases infarct sizes]. Herz. 2016 Oct 26. IF 0.751
  • Jäger B, Farhan S, Rohla M, Christ G, Podczeck-Schweighofer A, Schreiber W, Laggner AN, Weidinger F, Stefenelli T, Delle-Karth G, Kaff A, Maurer G, Huber K; Vienna STEMI Registry Group.. Clinical predictors of patient related delay in the VIENNA ST-elevation myocardial infarction network and impact on long-term mortality. Eur Heart J Acute Cardiovasc Care. 2017 Apr;6(3):254-261.
  • Rohla M, Tentzeris I, Freynhofer MK, Farhan S, Jarai R, Egger F, Weiss TW, Wojta J, Geppert A, Kastrati A, Stone GW, Huber K. Impact of bivalirudin on mortality and bleeding complications in acute coronary syndrome patients undergoing invasive revascularization: A real world experience. Wien Klin Wochenschr. 2016 Dec;128(23-24):906-915. IF 0.836
  • Vargas KG, Kassem M, Mueller C, Wojta J, Huber K. Copeptin for the early rule-out of non-ST-elevation myocardial infarction. Int J Cardiol. 2016 Nov 15;223:797-804. IF 4.638
  • Vogel B, Farhan S, Hahne S, Kozanli I, Kalla K, Freynhofer MK, Jarai R, Kautzky-Willer A, Huber K. Sex-related differences in baseline characteristics, management and outcome in patients with acute coronary syndrome without ST-segment elevation. Eur Heart J Acute Cardiovasc Care. 2016 Aug;5(4):347-53.
  • Weihs V, Szücs D, Fellner B, Eber B, Weihs W, Lambert T, Metzler B, Titscher G, Hochmayer B, Dechant C, Eder V, Siostrzonek P, Leisch F, Pichler M, Pachinger O, Gaul G, Weber H, Podczeck-Schweighofer A, Nesser HJ, Huber K. Electrocardiogram changes and wall motion abnormalities in the acute phase of Tako-Tsubo syndrome. Eur Heart J Acute Cardiovasc Care. 2016 Oct;5(6):481-488.

Publications SDG:

  • Enayati M, Eilenberg M, Grasl C, Riedl P, Kaun C, Messner B, Walter I, Liska R, Schima H, Wojta J, Podesser BK, Bergmeister H. Biocompatibility assessment of a new biodegradable vascular graft via in vitro co-culture approaches and in vivo model. Ann Biomed Eng. 2016 Nov;44(11):3319-3334. IF 2.887
  • Haider T, Plasenzotti R, Bergmeister H, Mach G, Kleinpeter G, Aguilar-Perez M, Sherif C. New mechanical thrombectomy model in the rabbit: A feasibility study. J Neurosci Methods. 2016 Sep 15;271:139-42. IF 2.053
  • Sherif C, Herbich E, Plasenzotti R, Bergmeister H, Windberger U, Mach G, Sommer G, Holzapfel GA, Haider T, Krssak M, Kleinpeter G. Very large and giant microsurgical bifurcation aneurysms in rabbits: Proof of feasibility and comparability using computational fluid dynamics and biomechanical testing. J Neurosci Methods. 2016 Aug 1;268:7-13. IF 2.053

Associated publications of the LBC for Cardiovascular Research 2016

Original papers and reviews on which PIs or project-associated co-workers appear as co-authors (highlighted in bold) are considered to be associated publications of the cluster and are listed below.

 

  • Alexander JH, Andersson U, Lopes RD, Hijazi Z, Hohnloser SH, Ezekowitz JA, Halvorsen S, Hanna M, Commerford P, Ruzyllo W, Huber K, Al-Khatib SM, Granger CB, Wallentin L; Apixaban for Reduction of Stroke and Other Thromboembolic Complications in Atrial Fibrillation (ARISTOTLE) Investigators. Apixaban 5 mg twice daily and clinical outcomes in patients with atrial fibrillation and advanced age, low body weight, or high creatinine: a secondary analysis of a randomized clinical trial. JAMA Cardiol. 2016 Sep 1;1(6):673-81.
  • Arras MM, Jana R, Mühlstaedt M, Maenz S, Andrews J, Su Z, Grasl C, Jandt KD. In situ formation of nanohybrid shish-kebabs during electrospinning for the creation of hierarchical shish-kebab structures. Macromolecules 2016; 49(9):3550-3558 IF: 5.800
  • Bartko J, Schoergenhofer C, Schwameis M, Buchtele N, Wojta J, Schabbauer G, Stiebellehner L, Jilma B. Dexamethasone inhibits endotoxin-induced coagulopathy in human lungs. J Thromb Haemost. 2016 Dec;14(12):2471-2477. IF 5.565
  • Beer L, Mildner M, Gyöngyösi M, Ankersmit HJ. Peripheral blood mononuclear cell secretome for tissue repair. Apoptosis. 2016 Dec;21(12):1336-1353. IF 3.592
  • De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Collet JP, Halvorsen S, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Ricci F, Sibbing D, Siegbahn A, Storey RF, Ten Berg J, Verheugt FW, Weitz JI. Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease. Thromb Haemost. 2016 Apr;115(4):685-711. IF 5.255
  • Dimitrov K, Riebandt J, Haberl T, Wiedemann D, Simon P, Laufer G, Schima H, Zimpfer D. High-intensity transient signals in the outflow graft and thrombosis of a HeartWare left ventricular assist device. Ann Thorac Surg. 2016 Mar;101(3):e83-5. IF 3.201
  • Eilenberg W, Stojkovic S, Piechota-Polanczyk A, Kaun C, Rauscher S, Gröger M, Klinger M, Wojta J, Neumayer C, Huk I, Demyanets S. Neutrophil gelatinase-associated lipocalin (NGAL) is associated with symptomatic carotid atherosclerosis and drives pro-inflammatory state in vitro. Eur J Vasc Endovasc Surg. 2016 May;51(5):623-31. IF 2.912
  • Farhan S, Freynhofer MK, Brozovic I, Bruno V, Vogel B, Tentzeris I, Baumgartner-Parzer S, Huber K, Kautzky-Willer A. Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study. Cardiovasc Diabetol. 2016 Apr 8;15:60. IF 4.534
  • Hayer S, Bauer G, Willburger M, Sinn K, Alasti F, Plasenzotti R, Shvets T, Niederreiter B, Aschauer C, Steiner G, Podesser BK, Smolen JS, Redlich K. Cartilage damage and bone erosion are more prominent determinants of functional impairment in longstanding experimental arthritis than synovial inflammation. Dis Model Mech. 2016 Nov 1;9(11):1329-1338. IF 4.316
  • Hauser JA, Demyanets S, Rusai K, Goritschan C, Weber M, Panesar D, Rindler L, Taylor AM, Marculescu R, Burch M, Wojta J, Michel-Behnke I. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure. Heart. 2016 Oct 15;102(20):1633-9. IF 5.693
  • Hemmeryckx B, Hohensinner P, Swinnen M, Heggermont W, Wojta J, Lijnen HR. Antioxidant treatment improves cardiac dysfunction in a murine model of premature aging. J Cardiovasc Pharmacol. 2016 Nov;68(5):374-382. IF 2.462
  • Jilma-Stohlawetz P, Quehenberger P, Schima H, Stoiber M, Knöbl P, Steinlechner B, Felli A, Jilma B. Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent. Thromb Res. 2016 Jan;137:196-201. IF 2.320
  • Kapeller B, Mueller J, Losert U, Podesser BK, Macfelda K. Microcurrent stimulation promotes reverse remodelling in cardiomyocytes. ESC Heart Fail. 2016 Jun;3(2):122-130.
  • Koller L, Hohensinner P, Sulzgruber P, Blum S, Maurer G, Wojta J, Hülsmann M, Niessner A. Prognostic relevance of circulating endothelial progenitor cells in patients with chronic heart failure. Thromb Haemost. 2016 Aug 1;116(2):309-16. IF 5.255
  • Kriz R, Freynhofer MK, Weiss TW, Egger F, Gruber SC, Eisenburger P, Wojta J, Huber K, Koch J. Safety and efficacy of pharmacological cardioversion of recent-onset atrial fibrillation: a single-center experience. Am J Emerg Med. 2016 Aug;34(8):1486-90. IF 1.504
  • Lambert T, Nahler A, Rohla M, Reiter C, Grund M, Kammler J, Blessberger H, Kypta A, Kellermair J, Schwarz S, Starnawski JA, Lichtenauer M, Weiss TW, Huber K, Steinwender C. Endpoint design for future renal denervation trials – Novel implications for a new definition of treatment response to renal denervation. Int J Cardiol. 2016 Oct 1;220:273-8. IF 4.638
  • Lincoff AM, Mehran R, Povsic TJ, Zelenkofske SL, Huang Z, Armstrong PW, Steg PG, Bode C, Cohen MG, Buller C, Laanmets P, Valgimigli M, Marandi T, Fridrich V, Cantor WJ, Merkely B, Lopez-Sendon J, Cornel JH, Kasprzak JD, Aschermann M, Guetta V, Morais J, Sinnaeve PR, Huber K, Stables R, Sellers MA, Borgman M, Glenn L, Levinson AI, Lopes RD, Hasselblad V, Becker RC, Alexander JH; REGULATE-PCI Investigators.. Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomized clinical trial. Lancet. 2016 Jan 23;387(10016):349-56. IF 44.002
  • Montalescot G, van 't Hof AW, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Collet JP, Goodman SG, Hammett CJ, Huber K, Janzon M, Lapostolle F, Lassen JF, Licour M, Merkely B, Salhi N, Silvain J, Storey RF, Ten Berg JM, Tsatsaris A, Zeymer U, Vicaut E, Hamm CW; ATLANTIC Investigators.. Effect of pre-hospital ticagrelor during the first 24 h after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: the ATLANTIC-H²⁴ analysis. JACC Cardiovasc Interv. 2016 Apr 11;9(7):646-56. IF 7.630
  • Nijenhuis VJ, Bennaghmouch N, Hassell M, Baan J Jr, van Kuijk JP, Agostoni P, van 't Hof A, Kievit PC, Veenstra L, van der Harst P, van den Heuvel AF, den Heijer P, Kelder JC, Deneer VH, van der Kley F, Onorati F, Collet JP, Maisano F, Latib A, Huber K, Stella PR, Ten Berg JM. Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation. Am Heart J. 2016 Mar;173:77-85. IF 4.332
  • Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P,  Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S, Baumgartner H, Gaemperli O, Achenbach S, Agewall S, Badimon L, Baigent C, Bueno H, Bugiardini R, Carerj S, Casselman F, Cuisset T, Erol Ç, Fitzsimons D, Halle M, Hamm C, Hildick-Smith D, Huber K, Iliodromitis E, James S, Lewis BS, Lip GY, Piepoli MF,  Richter D, Rosemann T, Sechtem U, Steg PG, Vrints C, Luis Zamorano J; Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology.. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016 Jan 14;37(3):267-315. IF 15.064
  • Rohla M, Haberfeld H, Sinzinger H, Kritz H, Tscharre M, Freynhofer MK, Huber K, Weiss TW. Systematic screening for cardiovascular risk at pharmacies. Open Heart. 2016 Sep 19;3(2):e000497.
  • Rohla M, Haberfeld H, Tscharre M, Huber K, Weiss TW. Awareness, treatment, and control of hypertension in Austria: a multicentre cross-sectional study. J Hypertens. 2016 Jul;34(7):1432-40. IF 5.062
  • Rohla M, Nahler A, Lambert T, Reiter C, Gammer V, Grund M, Blessberger H, Kammler J, Kypta A, Saleh K, Huber K, Steinwender C, Weiss TW. Predictors of response to renal denervation for resistant arterial hypertension: a single center experience. J Hypertens. 2016 Jan;34(1):123-9. IF 5.062
  • Schneider KH, Aigner P, Holnthoner W, Monforte X, Nürnberger S, Rünzler D, Redl H, Teuschl AH. Decellularized human placenta chorion matrix as a favorable source of small-diameter vascular grafts. Acta Biomater. 2016;29:125-134. IF: 6.025
  • Schrutka L, Distelmaier K, Hohensinner P, Sulzgruber P, Lang IM, Maurer G, Wojta J, Hülsmann M, Niessner A, Koller L. Impaired high-density lipoprotein anti-oxidative function is associated with outcome in patients with chronic heart failure. J Am Heart Assoc. 2016 Dec 21;5(12). IF 5.117
  • Thiele H, Desch S, Piek JJ, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Noc M, Huber K, Fuernau G, de Waha S, Meyer-Saraei R, Schneider S, Windecker S, Savonitto S, Briggs A, Torremante P, Vrints C, Schuler G, Ceglarek U, Thiery J, Zeymer U; CULPRIT-SHOCK Investigators.. Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial. Am Heart J. 2016 Feb;172:160-9. IF 4.332
  • Tscharre M, Hauser C, Rohla M, Freynhofer MK, Wojta J, Huber K, Weiss TW. Epicardial adipose tissue and cardiovascular outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2016.
  • Vafaie M, Slagman A, Möckel M, Hamm C, Huber K, Müller C, Vollert JO, Blankenberg S, Katus HA, Liebetrau C, Giannitsis E, Searle J. Prognostic value of undetectable hs troponin T in suspected acute coronary syndrome. Am J Med. 2016 Mar;129(3):274-82. IF 5.610
  • van Slochteren FJ, van Es R, Gyöngyösi M, van der Spoel TI, Koudstaal S, Leiner T, Doevendans PA, Chamuleau SA. Three dimensional fusion of electromechanical mapping and magnetic resonance imaging for real-time navigation of intramyocardial cell injections in a porcine model of chronic myocardial infarction. Int J Cardiovasc Imaging. 2016 May;32(5):833-43. IF 1.880
  • Vranckx P, White HD, Huang Z, Mahaffey KW, Armstrong PW, Van de Werf F, Moliterno DJ, Wallentin L, Held C, Aylward PE, Cornel JH, Bode C, Huber K, Nicolau JC, Ruzyllo W, Harrington RA, Tricoci P. Validation of BARC bleeding criteria in patients with acute coronary syndromes: the TRACER trial. J Am Coll Cardiol. 2016 May 10;67(18):2135-44. IF 17.759
  • Weber C, Shantsila E, Hristov M, Caligiuri G, Guzik T, Heine GH, Hoefer IE, Monaco C, Peter K, Rainger E, Siegbahn A, Steffens S, Wojta J, Lip GY. Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis". Thromb Haemost. 2016 Sep 27;116(4):626-37. IF 5.255
  • Weiss TW, Aichinger J, Huber K, Speidl WS, Watzinger N, Zweiker R, Alber HF. Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction. Wien Klin Wochenschr. 2016 Jun;128(11-12):450-7. IF 0.836
  • Winter MP, Wiesbauer F, Alimohammadi A, Blessberger H, Pavo N, Schillinger M, Huber K, Wojta J, Lang IM, Maurer G, Goliasch G. Soluble galectin-3 is associated with premature myocardial infarction. Eur J Clin Invest. 2016 May;46(5):386-91. IF 2.687
  • Wonnerth A, Krychtiuk KA, Mayer FJ, Minar E, Wojta J, Schillinger M, Koppensteiner R, Hoke M. Red cell distribution width and mortality in carotid atherosclerosis. Eur J Clin Invest. 2016 Feb;46(2):198-204. IF 2.687
  • Wu J, Hafner C, Schramel JP, Kaun C, Krychtiuk KA, Wojta J, Boehme S, Ullrich R, Tretter EV, Markstaller K, Klein KU. Cyclic and constant hyperoxia cause inflammation, apoptosis and cell death in human umbilical vein endothelial cells. Acta Anaesthesiol Scand. 2016 Apr;60(4):492-501. IF 2.049
  • Wu J, Stefaniak J, Hafner C, Schramel JP, Kaun C, Wojta J, Ullrich R, Tretter VE, Markstaller K, Klein KU. Intermittent hypoxia causes inflammation and injury to human adult cardiac myocytes. Anesth Analg. 2016 Feb;122(2):373-80. IF 3.827

Publications of the LBC for Cardiovascular Research 2015

Only original papers or reviews on which either a PI or one of his/her co-workers associated with the respective project appear as first, last or corresponding author (highlighted in bold) are considered to be publications of the cluster.

Publications ASC:

  • Granegger M, Masetti M, Laohasurayodhin R, Schloglhofer T, Zimpfer D, Schima H, Moscato F. Continuous monitoring of aortic valve opening in rotary blood pump patients. IEEE Trans Biomed Eng. 2015 Oct 9. [Epub ahead of print] PubMed PMID: 26461795. IF: 2.347
  • Hayward C, Lim CP, Schima H, Macdonald P, Moscato F, Muthiah K, Granegger M. Pump Speed Waveform Analysis to Detect Aortic Valve Opening in Patients on Ventricular Assist Device Support. Artif Organs. 2015;39:704-9. IF: 2.05
  • Mazza G, Stoiber M, Pfeiffer D, Schima H. Atraumatic Pulsatile Leukocyte Circulation for Long-Term In Vitro Dynamic Culture and Adhesion Assays. Artif Organs. 2015;39:973-8. IF: 2050
  • Stoiber M, Messner B, Grasl C, Gschlad V, Bergmeister H, Bernhard D, Schima H. A method for mechanical characterization of small blood vessels and vascular grafts. Experimental Mechanics. 2015; 55:1591–1595. IF: 1.548

Publications INFO:

  • Gyöngyösi M, Wojakowski W, Lemarchand P, Lunde K, Tendera M, Bartunek J, Marban E, Assmus A, Henry TD, Traverse JH, Moyé LA, Sürder D, Corti R, Huikuri H, Miettinen J, Wöhrle J, Obradovic S, Roncalli J, Malliaras K, Pokushalov E, Romanov A, Kastrup J, Bergmann MW, Atsma DE, Diederichsen A, Edes I, Benedek I, Benedek T, Pejkov H, Nyolczas N, Pavo N, Bergler-Klein J, Pavo IJ, Sylven C, Berti S, Navarese EP, Maurer G, for the ACCRUE investigators. Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res. 2015;116:1346-60. IF: 11.019
  • Katsaros KM, Speidl WS, Demyanets S, Kastl SP, Krychtiuk KA, Wonnerth A, Zorn G, Tentzeris I, Farhan S, Maurer G, Wojta J, Huber K. G-CSF predicts cardiovascular events in patients with stable coronary artery disease. PLoS One. 2015;10:e0142532. IF: 3.234
  • Kozarov E, Huber K, Wojta J. Infection-associated biomarkers of inflammation in atherosclerosis. Curr Pharm Des. 2015;21:1776-82. IF: 3.452
  • Krychtiuk KA, Kastl SP, Hofbauer SL, Wonnerth A, Goliasch G, Ozsvar-Kozma M, Katsaros KM, Maurer G, Huber K, Dostal E, Binder CJ, Pfaffenberger S, Oravec S, Wojta J, Speidl WS. Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a). J Clin Lipidol. 2015;9:533-41. IF: 3.904
  • Krychtiuk KA, Kastl SP, Pfaffenberger S, Lenz M, Hofbauer SL, Wonnerth A, Koller L, Katsaros KM, Pongratz T, Goliasch G, Niessner A, Gaspar L, Huber K, Maurer G, Dostal E, Wojta J, Oravec S, Speidl WS. Association of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease. PLoS One. 2015;10:e0123367. IF: 3.234
  • Krychtiuk KA, Ruhittel S, Hohensinner PJ, Koller L, Kaun C, Lenz M, Bauer B, Wutzlhofer L, Draxler DF, Maurer G, Huber K, Wojta J, Heinz G, Niessner A, Speidl WS. Mitochondrial DNA and toll-like receptor-9 are associated with mortality in critically ill Patients. Crit Care Med. 2015;43:2633-41. IF: 6.312
  • Krychtiuk KA, Watzke L, Kaun C, Buchberger E, Hofer-Warbinek R, Demyanets S, Pisoni J, Kastl SP, Rauscher S, Gröger M, Aliabadi A, Zuckermann A, Maurer G, de Martin R, Huber K, Wojta J, Speidl WS. Levosimendan exerts anti-inflammatory effects on cardiac myocytes and endothelial cells in vitro. Thromb Haemost. 2015;113:350-62. IF: 4.984
  • Stojkovic S, Ristl R, Moser FT, Wolzt M, Wojta J, Schmidinger H, Pezawas T. T-wave variability for the prediction of fast ventricular arrhythmias – prospective, observer-blind study. Circ J. 2015;79:318-24. IF: 3.940
  • Wojta J. Platelet-derived microparticles in patients with high cardiovascular risk and subclinical atherosclerosis. Thromb Haemost. 2015;114:1099. IF: 4.984

Publications REM:

  • Santer D, Nagel F, Kreibich M, Dzilic E, Moser PT, Muschitz G, Inci M, Krssak M, Plasenzotti P, Bergmeister H, Trescher K, Podesser BK. In vivo and ex vivo functional characterization of left ventricular remodelling after myocardial infarction in mice. ESC Heart Failure. 2015;2:171-177.
  • Trescher K, Dzilic E, Kreibich M, Gasser H, Aumayr K, Kerjaschki D, Pelzmann B, Hallström S, Podesser BK. The nitric oxide donor, S-nitroso human serum albumin, as an adjunct to HTK-N cardioplegia improves protection during cardioplegic arrest after myocardial infarction in rats. Interact Cardiovasc Thorac Surg. 2015;20:387-94. IF: 1.155

Publications BIO:

  • Andric T, Weiss TW, Huber K, Arnesen H, Seljeflot I. Effects of diet and/or n-3 fatty acid supplementation on components of the interleukin-6 trans-signalling system in elderly men. Scand J Clin Lab Invest. 2015;75:646-51. IF: 1.989
  • Aradi D, Collet JP, Mair J, Plebani M, Merkely B, Jaffe AS, Möckel M, Giannitsis E, Thygesen K, ten Berg JM, Mueller C, Storey RF, Lindahl B, Huber K;  Study Group on Biomarkers in Cardiology of the Acute Cardiovascular Care Association of the European Society of Cardiology; Working Group on Thrombosis of the European Society of Cardiology. Platelet function testing in acute cardiac care - is there a role for prediction or prevention of stent thrombosis and bleeding? Thromb Haemost. 2015;113:221-30. IF: 4.984
  • Freynhofer MK, Gruber SC, Grove EL, Weiss TW, Wojta J, Huber K. Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testing. Thromb Haemost. 2015;114:459-68. IF: 4.984
  • Huber K. Prasugrel in clopidogrel nonresponders: a way to improve secondary prevention in patients after percutaneous coronary intervention? JACC Cardiovasc Interv. 2015;8:1571-3. IF: 7.345
  • Jäger B, Farhan S, Kalla K, Glogar HD, Christ G, Karnik R, Norman G, Prachar H, Schreiber W, Kaff A, Podczeck-Schweighofer A, Weidinger F, Stefenelli T, Delle-Karth G, Laggner AN, Maurer G, Huber K; Vienna STEMI Registry Group. One-year mortality in patients with acute ST-elevation myocardial infarction in the Vienna STEMI registry. Wien Klin Wochenschr. 2015;127:535-42. IF: 0.836
  • Rohla M, Vennekate CK, Tentzeris I, Freynhofer MK, Farhan S, Egger F, Weiss TW, Wojta J, Granger CB, Huber K. Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery disease. Int J Cardiol. 2015;184:108-14. IF: 4.036
  • Schrör K, Huber K. Platelets, inflammation and anti-inflammatory drugs in ACS and CAD. Thromb Haemost. 2015;114:446-8. IF: 4.984
  • Siller-Matula JM, Trenk D, Schrör K, Gawaz M, Kristensen SD, Storey RF, Huber K; European Platelet Academy. How to improve the concept of individualised antiplatelet therapy with P2Y12 receptor inhibitors--is an algorithm the answer? Thromb Haemost. 2015;113:37-52. IF: 4.984

Publications SDG:

  • Bergmeister H, Seyidova N, Schreiber C, Strobl M, Grasl C, Walter I, Messner B, Baudis S, Fröhlich S, Marchetti-Deschmann M, Griesser M, di Franco M, Krssak M, Liska R, Schima H.  Biodegradable, thermoplastic polyurethane grafts for small diameter vascular replacements. Acta Biomater. 2015;11:104-13. IF: 6.025

 

Associated publications of the LBC for Cardiovascular Research 2015

Original papers and reviews on which PIs or project-associated co-workers appear as co-authors (highlighted in bold) are considered to be associated publications of the cluster and are listed below.

  • Andreotti F, Rocca B, Husted S, Ajjan RA, ten Berg J, Cattaneo M, Collet JP,  De Caterina R, Fox KA, Halvorsen S, Huber K, Hylek EM, Lip GY, Montalescot G, Morais J, Patrono C, Verheugt FW, Wallentin L, Weiss TW, Storey RF; ESC Thrombosis Working Group. Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J. 2015;36:3238-49. IF: 15.203
  • Aradi D, Kirtane A, Bonello L, Gurbel PA, Tantry US, Huber K, Freynhofer MK, ten Berg J, Janssen P, Angiolillo DJ, Siller-Matula JM, Marcucci R, Patti G, Mangiacapra F, Valgimigli M, Morel O, Palmerini T, Price MJ, Cuisset T, Kastrati A, Stone GW, Sibbing D. Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. Eur Heart J. 2015;36:1762-71. IF: 15.203
  • Aulin J, Siegbahn A, Hijazi Z, Ezekowitz MD, Andersson U, Connolly SJ, Huber K, Reilly PA, Wallentin L, Oldgren J. Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation. Am Heart J. 2015;170:1151-60. IF: 4.463
  • Beer L, Zimmermann M, Mitterbauer A, Ellinger A, Gruber F, Narzt MS, Zellner M, Gyöngyösi M, Madlener S, Simader E, Gabriel C, Mildner M, Ankersmit HJ. Analysis of the secretome of apoptotic peripheral blood mononuclear cells: impact of released proteins and exosomes for tissue regeneration. Sci Rep. 2015;5:16662. IF: 5.578
  • Beitzke D, Berger-Kulemann V, Schöpf V, Unterhumer S, Spitzer E, Feuchtner GM, Gyöngyösi M, Uyanik-Uenal K, Zuckermann A, Loewe C, Wolf F. Dual-source cardiac computed tomography angiography (CCTA) in the follow-up of cardiac transplant: comparison of image quality and radiation dose using three different imaging protocols. Eur Radiol. 2015;25:2310-7. IF: 4.014
  • Boriani G, Lane DA, Windecker S, Huber K, Kirchhof P, Lip GY. Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice. Europace. 2015;17:1319-22. IF: 3.670
  • Capodanno D, Lip GY, Windecker S, Huber K, Kirchhof P, Boriani G, Lane D, Gilard M, Collet JP, Valgimigli M, Byrne RA. Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement. EuroIntervention. 2015;10:1015-21. IF: 3.322
  • Clemmensen P, Roe MT, Hochman JS, Cyr DD, Neely ML, McGuire DK, Cornel JH, Huber K, Zamoryakhin D, White HD, Armstrong PW, Fox KA, Prabhakaran D, Ohman EM; TRILOGY ACS Investigators. Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial. Am Heart J. 2015;170:695-705. IF: 4.463
  • De Luca G, Van't Hof AW, Gibson  IF: 4.463CM, Cutlip D, Zeymer U, Noc M, Maioli M, Zorman S, Gabriel HM, Emre A, Rakowski T, Gyongyosi M, Huber K, Bellandi F, Dudek D; EGYPT cooperation. Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation). Am J Cardiol. 2015;115:711-5. IF: 3.276
  • Distelmaier K, Wiesbauer F, Blessberger H, Oravec S, Schrutka L, Binder C, Dostal E, Schillinger M, Wojta J, Lang IM, Maurer G, Huber K, Goliasch G. Impaired antioxidant HDL function is associated with premature myocardial infarction. Eur J Clin Invest. 2015;45:731-8. IF: 2.734
  • Duschek N, Stojakovic T, Ghai S, Strassegger J, Basic J, Scharnagl H, Falkensammer J, Huber K, Assadian A. Ratio of apolipoprotein A-II/B improves risk prediction of postoperative survival after carotid endarterectomy. Stroke. 2015;46:1700-3. IF: 5.761
  • Falkensammer J, Frech A, Duschek N, Gasteiger S, Stojakovic T, Scharnagl H, Huber K, Fraedrich G, Greiner A. Prognostic relevance of ischemia-modified albumin and NT-proBNP in patients with peripheral arterial occlusive disease. Clin Chim Acta.;438:255-60. IF: 2.824
  • Fröhlich SM, Eilenberg M, Svirkova A, Grasl C, Liska R, Bergmeister H, Marchetti-Deschmann M. Mass spectrometric imaging of in vivo protein and lipid adsorption on biodegradable vascular replacement systems. Analyst. 2015;140:6089-99. IF: 4.107
  • Gershlick AH, Westerhout CM, Armstrong PW, Huber K, Halvorsen S, Steg PG, Ostojic M, Goldstein P, Carvalho AC, Van de Werf F, Wilcox RG. Impact of a pharmacoinvasive strategy when delays to primary PCI are prolonged. Heart. 2015;101:692-8. IF: 5.595
  • Goliasch G, Wiesbauer F, Blessberger H, Demyanets S, Wojta J, Huber K, Maurer G, Schillinger M, Speidl WS. Premature myocardial infarction is strongly associated with increased levels of remnant cholesterol. J Clin Lipidol. 2015;9:801-6. IF: 3.904
  • Gorenek B, Blomström Lundqvist C, Brugada Terradellas J, Camm AJ, Hindricks G, Huber K, Kirchhof P, Kuck KH, Kudaiberdieva G, Lin T, Raviele A, Santini M, Tilz RR, Valgimigli M, Vos MA, Vrints C, Zeymer U. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. EuroIntervention. 2015;10:1095-108. IF: 3.322
  • Gorenek B, Lundqvist CB, Terradellas JB, Camm AJ, Hindricks G, Huber K, Kirchhof P, Kuck KH, Kudaiberdieva G, Lin T, Raviele A, Santini M, Tilz RR, Valgimigli M, Vos MA, Vrints C, Zeymer U. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Eur Heart J Acute Cardiovasc Care. 2015;4:386.
  • Haider T, Höftberger R, Rüger B, Mildner M, Blumer R, Mitterbauer A, Buchacher T, Sherif C, Altmann P, Redl H, Gabriel C, Gyöngyösi M, Fischer MB, Lubec G, Ankersmit HJ. The secretome of apoptotic human peripheral blood mononuclear cells attenuates secondary damage following spinal cord injury in rats. Exp Neurol. 2015;267:230-42. IF: 4.694
  • Helseth R, Weiss TW, Opstad TB, Siegbahn A, Solheim S, Freynhofer MK, Huber K, Arnesen H, Seljeflot S. Associations between circulating proteins and corresponding genes expressed in coronary thrombi in patients with acute myocardial infarction. Thromb Res. 2015;136:1240-4. IF: 2.447
  • Helseth R, Seljeflot I, Opstad T, Solheim S, Freynhofer M, Arnesen H, Huber K, Weiss T. Genes expressed in coronary thrombi are associated with ischemic time in patients with acute myocardial infarction. Thromb Res. 2015;135:329-33. IF: 2.447
  • Jugdaohsingh R, Kessler K, Messner B, Stoiber M, Pedro LD, Schima H, Laufer G, Powell JJ, Bernhard D. Dietary Silicon Deficiency Does Not Exacerbate Diet-Induced Fatty Lesions in Female ApoE Knockout Mice. J Nutr. 2015;145:1498-506. IF: 3.875
  • Koller L, Rothgerber DJ, Sulzgruber P, El-Hamid F, Förster S, Wojta J, Goliasch G, Maurer G, Niessner A. History of previous bleeding and C-reactive protein improve assessment of bleeding risk in elderly patients (≥ 80 years) with myocardial infarction. Thromb Haemost. 2015;114:1085-91. IF: 4.984
  • Möckel M, Searle J, Hamm C, Slagman A, Blankenberg S, Huber K, Katus H, Liebetrau C, Müller C, Muller R, Peitsmeyer P, von Recum J, Tajsic M, Vollert JO, Giannitsis E. Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J. 2015;36:369-76. IF: 15.203
  • Pellaton C, Cayla G, Silvain J, Zeymer U, Cohen M, Goldstein P, Huber K, Pollack C Jr, Kerneis M, Collet JP, Vicaut E, Montalescot G; ATOLL Investigators. Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up trial. Am Heart J. 2015;170:778-86. IF: 4.463
  • Piechota-Polanczyk A, Demyanets S, Mittlboeck M, Hofmann M, Domenig CM, Neumayer C, Wojta J, Klinger M, Nanobachvili J, Huk I. The influence of simvastatin on NGAL, matrix metalloproteinases and their tissue inhibitors in human intraluminal thrombus and abdominal aortic aneurysm tissue. Eur J Vasc Endovasc Surg. 2015;49:549-55. IF: 2.490
  • Rubboli A, Agewall S, Huber K, Lip GY. New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint. Int J Cardiol. 2015;196:133-8. IF: 4.036
  • Rungatscher A, Hallström S, Linardi D, Milani E, Gasser H, Podesser BK, Scarabelli TM, Luciani GB, Faggian G. S-nitroso human serum albumin attenuates pulmonary hypertension, improves right ventricular-arterial coupling, and reduces oxidative stress in a chronic right ventricle volume overload model. J Heart Lung Transplant. 2015;34:479-88. IF: 6.650
  • Schuh, CM, Morton TJ, Banerjee A, Grasl C, Schima H, Schmidhammer R, Redl H, Ruenzler D. Activated Schwann cell-like cells on aligned fibrin-poly(lactic-co-glycolic acid) structures: a novel construct for application in peripheral nerve regeneration. Cells Tissues Organs. 2015;200:287-299. IF: 2.137
  • Shavadia J, Zheng Y, Dianati Maleki N, Huber K, Halvorsen S, Goldstein P, Gershlick AH, Wilcox R, Van de Werf F, Armstrong PW. Infarct size, shock, and heart failure: does reperfusion strategy matter in early presenting patients with ST-segment elevation myocardial infarction? J Am Heart Assoc. 2015;4:e002049. IF: 4.306
  • Springer A, Kratochwill K, Bergmeister H, Csaicsich D, Huber J, Mayer B, Mühlberger I, Stahlschmidt J, Subramaniam R, Aufricht C. A fetal sheep model for studying compensatory mechanisms in the healthy contralateral kidney after unilateral ureteral obstruction. J Pediatr Urol. 2015;11:352.e1-7. IF: 0.898
  • Sulzgruber P, Koller L, Reiberger T, El-Hamid F, Forster S, Rothgerber DJ, Goliasch G, Wojta J, Niessner A. Butyrylcholinesterase predicts cardiac mortality in young patients with acute coronary syndrome. PLoS One. 2015;10:e0123948. IF: 3.234

Publications of the LBC for Cardiovascular Research 2014

Only original papers or reviews on which either a PI or one of his/her co-workers associated with the respective project appear as first, last or corresponding author (highlighted in bold) are considered to be publications of the cluster.

 

Publications ASC:

  • Granegger M, Schima H, Zimpfer D, Moscato F. Assessment of aortic valve opening during rotary blood pump support using pump signals. Artif Organs. 2014 Apr;38(4):290-7. IF 1.870 Schima H, Stoiber M, Schlöglhofer T, Hartner Z, Haberl T, Zimpfer D. Repair of left ventricular assist device driveline damage directly at the transcutaneous exit site. Artif Organs. 2014 May;38(5):422-5. IF 1.870
  • Juraszek A, Dziodzio T, Stoiber M, Fechtig D, Gschlad V, Aigner P, Czerny M, Schima H. The influence of bicuspid aortic valves on the dynamic pressure distribution in the ascending aorta: a porcine ex vivo model. Eur J Cardiothorac Surg. 2014 Sep;46(3):349-55; discussion 355. IF 3.048
  • Moscato F, Granegger M, Edelmayer M, Zimpfer D, Schima H. Continuous monitoring of cardiac rhythms in left ventricular assist device patients. Artif Organs. 2014 Mar;38(3):191-8. IF 1.870
  • Schima H, Schlöglhofer T, zu Dohna R, Drews T, Morshuis M, Roefe D, Schmitto JD, Strüber M, Zimpfer D. Usability of ventricular assist devices in daily experience: a multicenter study. Artif Organs. 2014 Sep;38(9):751-60. IF 1.870
  • Schima H, Zrunek P, Stoiber M, Larose J, Shambaugh C, Tamez D, Deckert Z, Plasenzotti R, Bergmeister H, Wieselthaler G. Extended in vivo evaluation of a miniaturized axial flow pump with a novel inflow cannula for a minimal invasive implantation procedure. J Heart Lung Transplant. 2014 Apr;33(4):422-8. IF 5.611
  • Schlöglhofer T, Gilly H, Schima H. Semi-invasive measurement of cardiac output based on pulse contour: a review and analysis. Can J Anaesth. 2014 May;61(5):452-79. IF 2.495

 

Publications INFO:

  • Demyanets S, Tentzeris I, Jarai R, Katsaros KM, Farhan S, Wonnerth A, Weiss TW, Wojta J, Speidl WS, Huber K. An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis. Cytokine. 2014 Jun;67(2):65-70. IF 2.847
  • Demyanets S, Speidl WS, Tentzeris I, Jarai R, Katsaros KM, Farhan S, Krychtiuk KA, Wonnerth A, Weiss TW, Huber K, Wojta J. Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome. PLoS One. 2014 Apr 21;9(4):e95055. IF 3.534
  • Katsaros KM, Kastl SP, Krychtiuk KA, Hutter R, Zorn G, Maurer G, Huber K, Wojta J, Christ G, Speidl WS. An increase of VEGF plasma levels is associated with restenosis of drug-eluting stents. EuroIntervention. 2014 Jun;10(2):224-30. IF 3.758
  • Krychtiuk KA, Nürnberg M, Volker R, Pachinger L, Jarai R, Freynhofer MK, Wojta J, Huber K, Weiss TW. Effects of AV-delay optimization on hemodynamic parameters in patients with VDD pacemakers. Wien Klin Wochenschr. 2014 May;126(9-10):270-7. IF 0.791
  • Krychtiuk KA, Kastl SP, Pfaffenberger S, Pongratz T, Hofbauer SL, Wonnerth A, Katsaros KM, Goliasch G, Gaspar L, Huber K, Maurer G, Dostal E, Oravec S, Wojta J, Speidl WS. Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease. Atherosclerosis. 2014 Dec;237(2):589-96. IF 3.991
  • Pavo N, Charwat S, Nyolczas N, Jakab A, Murlasits Z, Bergler-Klein J, Nikfardjam M, Benedek I, Benedek T, Pavo IJ, Gersh BJ, Huber K, Maurer G, Gyöngyösi M. Cell therapy for human ischemic heart diseases: Critical review and summary of the clinical experiences. J Mol Cell Cardiol. 2014;75:12-24. IF 5.218
  • Pavo N, Emmert MY, Giricz Z, Varga ZV, Ankersmit HJ, Maurer G, Hoerstrup SP, Ferdinandy P, Wu JC, Gyöngyösi M. Real-time visualization of ischemic burden during repetitive ischemia/reperfusion. JACC Cardiovasc Imaging 20142014 Sep;7(9):956-8. IF 6.986
  • Pavo N, Jakab A, Emmert MY, Strebinger G, Wolint P, Zimmermann M, Ankersmit HJ, Hoerstrup SP, Maurer G, Gyöngyösi M. Comparison of NOGA endocardial mapping and cardiac magnetic resonance imaging for determining infarct size and infarct transmurality for intramyocardial injection therapy using experimental data. PLoS One. 2014;9(11):e113245. IF 3.534
  • Pavo N, Zimmermann M, Pils D, Mildner M, Petrási Z, Petneházy O, Fuzik J, Jakab A, Gabriel C, Sipos W, Maurer G, Gyöngyösi M*, Ankersmit HJ. Long-acting beneficial effect of percutaneously intramyocardially delivered secretome of apoptotic peripheral blood cells on porcine chronic ischemic left ventricular dysfunction. Biomaterials. 2014 Apr;35(11):3541-50. *equally contributed to last authorship IF 8.312
  • Stojkovic S, Kaun C, Heinz M, Krychtiuk KA, Rauscher S, Lemberger CE, de Martin R, Gröger M, Petzelbauer P, Huk I, Huber K, Wojta J, Demyanets S. Interleukin-33 induces urokinase in human endothelial cells--possible impact on angiogenesis. J Thromb Haemost. 2014 Jun;12(6):948-57. IF 5.550
  • Wonnerth A, Katsaros KM, Krychtiuk KA, Speidl WS, Kaun C, Thaler K, Huber K, Wojta J, Maurer G, Seljeflot I, Arnesen H, Weiss TW. Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels. Metabolism. 2014 May;63(5):647-53. IF 0

 

Publications BIO:

  • Egger F, Nürnberg M, Rohla M, Weiss TW, Unger G, Smetana P, Geppert A, Gruber SC, Bambazek A, Falkensammer J, Waldenberger FR, Huber K, Freynhofer MK. High-degree atrioventricular block in patients with preexisting bundle branch block or bundle branch block occurring during transcatheter aortic valve implantation. Heart Rhythm. 2014 Dec;11(12):2176-82. IF 4.918
  • Freynhofer MK, Bruno V, Brozovic I, Jarai R, Vogel B, Farhan S, Hübl W, Willheim M, Wojta J, Huber K. Variability of on-treatment platelet reactivity in patients on clopidogrel. Platelets. 2014;25(5):328-36. IF 2.627
  • Halvorsen S, Huber K. Fibrinolytic treatment of ST-elevation myocardial infarction. Update 2014. Hamostaseologie. 2014 Feb 4;34(1):47-53. IF 1.589
  • Höchtl T, Huber K. P2Y12-receptor-inhibiting antiplatelet strategies in acute coronary syndromes. Hamostaseologie. 2014 Feb 4;34(1):20-8. IF 1.589
  • Höchtl-Hainzl T, Huber K. Direct anticoagulants for atrial fibrillation. Update 2014. Herz. 2014 May;39(3):357-67. IF 0.912
  • Huber K, Bates ER, Valgimigli M, Wallentin L, Kristensen SD, Anderson JL, Lopez Sendon JL, Tubaro M, Granger CB, Bode C, Ohman EM, Steg PG. Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold? Am Heart J. 2014 Nov;168(5):611-21. IF 4.555
  • Rohla M, Freynhofer MK, Hammerl H, Weiss TW, Huber K. Stroke and recurrent left atrial appendage thrombus in a patient with atrial fibrillation under old and new oral anticoagulants: a case report. Thromb Haemost. 2014 Feb;111(2):375-8. IF 5.760
  • Rohla M, Freynhofer MK, Tentzeris I, Farhan S, Wojta J, Huber K, Weiss TW. Plasma osmolality predicts clinical outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2014 Mar;3(1):84-92. IF 0
  • Tentzeris I, Rohla M, Jarai R, Farhan S, Freynhofer MK, Unger G, Nürnberg M, Geppert A, Wessely E, Wojta J, Huber K. Influence of high-dose highly efficient statins on short-term mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary syndromes. Am J Cardiol. 2014 Apr 1;113(7):1099-104. IF 3.425

 

Publications SDG:

  • Sherif C, Kleinpeter G, Mach G, Loyoddin M, Haider T, Plasenzotti R, Bergmeister H, Di Ieva A, Gibson D, Krssak M. Evaluation of cerebral aneurysm wall thickness in experimental aneurysms: comparison of 3T-MR imaging with direct microscopic measurements. Acta Neurochir (Wien). 2014 Jan;156(1):27-34. IF 1.788

 

Associated publications of the LBC for Cardiovascular Research 2014

Original papers and reviews on which PIs or project-associated co-workers appear as co-authors (highlighted in bold) are considered to be associated publications of the cluster and are listed below.

 

  • Adlbrecht C, Huber K, Reynolds HR, Carvalho AC, Džavík V, Steg PG, Liu L, Marino P, Pearte CA, Rankin JM, White HD, Lamas GA, Hochman JS. Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction. Int J Cardiol. 2014 Jun 1;174(1):90-5. TOP 10% IF 6.175
  • Alias S, Redwan B, Panzenböck A, Winter MP, Schubert U, Voswinckel R, Frey MK, Jakowitsch J, Alimohammadi A, Hobohm L, Mangold A, Bergmeister H, Sibilia M, Wagner EF, Mayer E, Klepetko W, Hölzenbein TJ, Preissner KT, Lang IM. Defective angiogenesis delays thrombus resolution: a potential pathogenetic mechanism underlying chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):810-9. IF 5.550
  • Aradi D, Storey RF, Komócsi A, Trenk D, Gulba D, Kiss RG, Husted S, Bonello L, Sibbing D, Collet JP, Huber K; Working Group on Thrombosis of the European Society of Cardiology. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention. Eur Heart J. 2014 Jan;35(4):209-15. TOP 10% IF 14.723
  • Balogh A, Santer D, Pásztor ET, Tóth A, Czuriga D, Podesser BK, Trescher K, Jaquet K, Erdodi F, Edes I, Papp Z. Myofilament protein carbonylation contributes to the contractile dysfunction in the infarcted LV region of mouse hearts. Cardiovasc Res. 2014 Jan 1;101(1):108-19. IF 5.808
  • Beer L, Seemann R, Ristl R, Ellinger A, Kasiri MM, Mitterbauer A, Zimmermann M, Gabriel C, Gyöngyösi M, Klepetko W, Mildner M, Ankersmit HJ. High dose ionizing radiation regulates micro RNA and gene expression changes in human peripheral blood mononuclear cells. BMC Genomics. 2014 Sep 25;15:814. IF 4.041
  • Bergler-Klein J, Gyöngyösi M, Maurer G. The role of biomarkers in valvular heart disease: focus on natriuretic peptides. Can J Cardiol. 2014;30:1027-34. IF 3.940
  • Gouya G, Arrich J, Wolzt M, Huber K, Verheugt FW, Gurbel PA, Pirker-Kees A, Siller-Matula JM. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis. Stroke. 2014 Feb;45(2):492-503. TOP 10% IF 6.018
  • Haberl T, Riebandt J, Mahr S, Laufer G, Rajek A, Schima H, Zimpfer D. Viennese approach to minimize the invasiveness of ventricular assist device implantation. Eur J Cardiothorac Surg. 2014 Dec;46(6):991-6; discussion 996 IF 3.048
  • Koller L, Blum S, Korpak M, Richter B, Goliasch G, Zorn G, Brekalo M, Maurer G, Wojta J, Pacher R, Hülsmann M, Niessner A. Predictive power of the fractalkine receptor CX3CR1 on CD4 T cells in patients with chronic heart failure. Int J Cardiol. 2014 Jan 15;171(1):96-7. TOP 10%, IF 6.175
  • Krenn L, Kopp C, Glogar D, Lang IM, Delle-Karth G, Neunteufl T, Kreiner G, Kaider A, Bergler-Klein J, Khorsand A, Nikfardjam M, Laufer G, Maurer G, Gyöngyösi M. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention. Catheter Cardiovasc Interv. 2014 Dec 1;84(7):1029-39. IF 0
  • Kyrle PA, Binder K, Eichinger S, Függer R, Gollackner B, Hiesmayr JM, Huber K, Lang W, Perger P, Quehenberger P, Roithinger FX, Schmaldienst S, Weltermann A, Domanovits H. Dabigatran: patient management in specific clinical settings. Wien Klin Wochenschr. 2014 Sep;126(17-18):503-8. IF 0.791
  • Lichtenauer M, Schreiber C, Jung C, Beer L, Mangold A, Gyöngyösi M, Podesser BK, Ankersmit HJ. Myocardial infarct size measurement using geometric angle calculation. Eur J Clin Invest. 2014 Feb;44(2):160-7. IF 2.834
  • Riebandt J, Haberl T, Mahr S, Laufer G, Rajek A, Steinlechner B, Schima H, Zimpfer D. Preoperative patient optimization using extracorporeal life support improves outcomes of INTERMACS Level I patients receiving a permanent ventricular assist device. Eur J Cardiothorac Surg. 2014 Sep;46(3):486-92; discussion 492. IF 3.048
  • Riebandt J, Haberl T, Mahr S, Rajek A, Laufer G, Schima H, Zimpfer D. Off-pump HeartWare ventricular assist device implantation with outflow graft anastomosis to the left subclavian artery. Ann Thorac Surg. 2014 Jun;97(6):2214-6. IF 3.631
  • Sandner SE, Riebandt J, Haberl T, Mahr S, Rajek A, Schima H, Wieselthaler GM, Laufer G, Zimpfer D. Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation. J Heart Lung Transplant. 2014 Jan;33(1):88-93. IF 5.611

 

Publications of the LBC for Cardiovascular Research 2013

Only original papers or reviews on which either a PI or one of his/her co-workers associated with the respective project appear as first, last or corresponding author (highlighted in bold) are considered to be publications of the cluster.

 

Publications ASC:

  • Aigner P, Eskandary F, Schlöglhofer T, Gottardi R, Aumayr K, Laufer G, Schima H. Sternal force distribution during median sternotomy retraction. J Thorac Cardiovasc Surg. 2013;146:1381-6. IF: 3.526
  • Granegger M, Mahr S, Horvat J, Aigner P, Roehrich M, Stoiber M, Plasenzotti R, Zimpfer D, Schima H, Moscato F. Investigation of hemodynamics in the assisted isolated porcine heart. Int J Artif Organs. 2013;36:878-86. IF: 1.759
  • Moscato F, Wirrmann C, Granegger M, Eskandary F, Zimpfer D, Schima H. Use of continuous flow ventricular assist devices in patients with heart failure and a normal ejection fraction: a computer-simulation study. J Thorac Cardiovasc Surg. 2013;145:1352-8. IF: 3.526
  • Schima H, Schlöglhofer T, Hartner Z, Horvat J, Zimpfer D. Importance of linguistic details in alarm messages of ventricular assist devices. Int J Artif Organs. 2013;36:406-9. IF: 1.759
  • Schlöglhofer T, Aigner P, Stoiber M, Schima H. Fixation and mounting of porcine aortic valves for use in mock circuits. Int J Artif Organs. 2013;36:738-41. IF: 1.759
  • Stoiber M, Schlöglhofer T, Aigner P, Grasl C, Schima H. An alternative method to create highly transparent hollow models for flow visualization. Int J Artif Organs. 2013;36(2):131-4. IF: 1.75

 

Publications INFO:

  • Alessi MC, Wojta J. Obesity and vascular disease: from bench to bedside. Thromb Haemost. 2013;110:632-3. IF: 6.094
  • Demyanets S, Kaun C, Pentz R, Krychtiuk KA, Rauscher S, Pfaffenberger S, Zuckermann A, Aliabadi A, Gröger M, Maurer G, Huber K, Wojta J. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature. J Mol Cell Cardiol. 2013;60:16-26. IF: 5.148
  • Emmert MY, Wolint P, Winklhofer S, Stolzmann P, Cesarovic N, Fleischmann T, Nguyen TD, Frauenfelder T, Böni R, Scherman J, Bettex D, Grünenfelder J, Schwartlander R, Vogel V, Gyöngyösi M*, Alkadhi H, Falk V, Hoerstrup SP. Transcatheter based electromechanical mapping guided intramyocardial transplantation and in vivo tracking of human stem cell based three dimensional microtissues in the porcine heart. Biomaterials. 2013;34:2428-41. IF: 7.4 (*Leader of MUW Project)
  • Krychtiuk KA, Kastl SP, Speidl WS, Wojta J. Inflammation and coagulation in atherosclerosis. Hamostaseologie. 2013;33:269-82. IF: 1.479
  • Pfaffenberger S, Vyskocil E, Kollmann C, Unger E, Kaun C, Kastl S, Woeber C, Nawratil G, Huber K, Maurer G, Gottsauner-Wolf M, Wojta J. Transtemporal ultrasound application potentially elevates brain temperature: results of an anthropomorphic skull model. Ultraschall Med. 2013;34:51-7. IF: 4.116
  • Rega-Kaun G, Kaun C, Wojta J. More than a simple storage organ: adipose tissue as a source of adipokines involved in cardiovascular disease. Thromb Haemost. 2013;110:641-50. IF: 6.094

 

Publications REM:

  • Trescher K, Hasun M, Baumgartner A, Dietl W, Wolfsberger M, Hallström S, Podesser BK. New HTK-N46B cardioplegia provides superior protection during ischemia/reperfusion in failing hearts. J Cardiovasc Surg (Torino). 2013 J;54:413-21. IF: 1.510
  • Trescher K, Thometich B, Demyanets S, Kassal H, Sedivy R, Bittner R, Holzinger C, Podesser BK. Type A dissection and chronic dilatation: tenascin-C as a key factor in destabilization of the aortic wall. Interact Cardiovasc Thorac Surg. 2013;17:365-70. IF: 1.112

 

Publications BIO:

  • Freynhofer MK, Bruno V, Brozovic I, Jarai R, Vogel B, Farhan S, Hübl W, Willheim M, Wojta J, Huber K. Variability of on-treatment platelet reactivity in patients on clopidogrel. Platelets. 2013. [Epub ahead of print] IF: 2.240
  • Freynhofer MK, Draxler DF, Gruber SC, Bruno V, Höchtl T, Fellner B, Jakl-Kotauschek G, Wojta J, Pabinger-Fasching I, Huber K, Ay C. Endogenous t-PA- antigen is an independent predictor of adverse cardiovascular events and all-cause death in patients with atrial fibrillation. J Thromb Haemost. 2013;11:1069-77. IF: 6.081
  • Freynhofer MK, Gruber SC, Bruno V, Höchtl T, Farhan S, Zaller V, Wojta J, Huber K. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation. Int J Cardiol. 2013;168:317-25. IF: 5.509
  • Siller-Matula JM, Trenk D, Schrör K, Gawaz M, Kristensen SD, Storey RF, Huber K; EPA (European Platelet Academy). Response variability to P2Y12 receptor inhibitors: expectations and reality. JACC Cardiovasc Interv. 2013;6:1111-28. IF: 6.552

 

Publications SDG:

  • Bergmeister H, Schreiber C, Grasl C, Walter I, Plasenzotti R, Stoiber M, Bernhard D, Schima H. Healing characteristics of electrospun polyurethane grafts with various porosities. Acta Biomater. 2013;9:6032-40. IF: 5.093
  • Bergmeister H, Strobl M, Grasl C, Liska R, Schima H. Tissue engineering of vascular grafts. Eur Surg 2013;45:187-193. IF: 0.148
  • Grasl C., Arras MM, Stoiber M, Bergmeister H., Schima H., Electrodynamic control of the nanofiber alignment during electrospinning. Applied Physics Letters, 2013;102:053111. IF: 3.794
  • Mashayekhi R, Mobedi H, Najafi J, Enayati M., In-vitro/In-vivo comparison of leuprolide release from an in-situ forming plga system, DARU J Pharmt Sci, 2013;21:57 -64. IF:0.620
  • Sherif C, Kleinpeter G, Mach G, Loyoddin M, Haider T, Plasenzotti R, Bergmeister H, Di Ieva A, Gibson D, Krssak M. Evaluation of cerebral aneurysm wall thickness in experimental aneurysms: comparison of 3T-MR imaging with direct microscopic measurements. Acta Neurochir (Wien). 2014;156:27-34. IF: 1.546
  • Strobl M, Schreiber C, Panzenböck A, Winter MP, Bergmeister H, Jakowitsch J, Mascherbauer J, Lang IM, Wexberg P, Bonderman D. Exhaled nitric oxide measurement to monitor pulmonary hypertension in a pneumonectomy-monocrotaline rat model. Am J Physiol Lung Cell Mol Physiol. 2013;305:L485-90. IF: 3.523

 

Associated publications of the LBC for Cardiovascular Research 2013

Original papers and reviews on which PIs or project-associated co-workers appear as co-authors (highlighted in bold) are considered to be associated publications of the cluster and are listed below.

  • Awad EM, Khan SY, Sokolikova B, Brunner PM, Olcaydu D, Wojta J, Breuss JM, Uhrin P. Cold induces reactive oxygen species production and activation of the NF-kappa B response in endothelial cells and inflammation in vivo. J Thromb Haemost. 2013;11:1716-26.
  • Balogh A, Santer D, Pásztor ET, Tóth A, Czuriga D, Podesser BK, Trescher K, Jaquet K, Erdodi F, Edes I, Papp Z. Myofilament protein carbonylation contributes to the contractile dysfunction in the infarcted LV region of mouse hearts. Cardiovasc Res. 2014;101:108-19.
  • Benedek T, Gyöngyösi M, Benedek I. Multislice computed tomographic coronary angiography for quantitative assessment of culprit lesions in acute coronary syndromes. Can J Cardiol. 2013;29:364-71.
  • Benedek I, Gyongyosi M, Benedek T. A prospective regional registry of ST-elevation myocardial infarction in Central Romania: impact of the Stent for Life Initiative recommendations on patient outcomes. Am Heart J. 2013;166:457-65.
  • De Luca G, Gibson M, Cutlip D, Huber K, Dudek D, Bellandi F, Noc M, Maioli M, Zorman S, Zeymer U, Secco GG, Mesquita Gabriel H, Emre A, Arntz HR, Rakowski T, Gyongyosi M, Hof AW; EGYPT Cooperation. Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors. Arch Cardiovasc Dis. 2013 Mar;106(3):155-61.
  • De Luca G, Gibson CM, Huber K, Dudek D, Cutlip D, Zeymer U, Gyöngyösi M, Bellandi F, Noc M, Arntz HR, Maioli M, Secco GG, Zorman S, Gabriel HM, Emre A, Rakowski T, Van't Hof AW; EGYPT cooperation. Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. EuroIntervention. 2012;8:470-6.
  • De Luca G, van't Hof AW, Huber K, Gibson CM, Bellandi F, Arntz HR, Maioli M, Noc M, Zorman S, Zeymer U, Gabriel HM, Emre A, Cutlip D, Rakowski T, Gyongyosi M, Dudek D; EGYPT cooperation. Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplasty. Am J Cardiol. 2013;112:1083-6.
  • Duschek N, Ghai S, Sejkic F, Falkensammer J, Skrinjar E, Huber K, Wojta J, Waldhör T, Hübl W, Assadian A. Homocysteine improves risk stratification in patients undergoing endarterectomy for asymptomatic internal carotid artery stenosis. Stroke. 2013;44:2311-4.
  • Koller L, Blum S, Korpak M, Richter B, Goliasch G, Zorn G, Brekalo M, Maurer G, Wojta J, Pacher R, Hülsmann M, Niessner A. Predictive power of the fractalkine receptor CX3CR1 on CD4 T cells in patients with chronic heart failure. Int J Cardiol. 2014;171:96-7.
  • Koller L, Richter B, Goliasch G, Blum S, Korpak M, Zorn G, Brekalo M, Maurer G, Wojta J, Pacher R, Hülsmann M, Niessner A. CD4+ CD28(null) cells are an independent predictor of mortality in patients with heart failure. Atherosclerosis. 2013;230:414-6.
  • Lukács E, Magyari B, Tóth L, Petneházy Ö, Petrási Z, Simor T, Gyöngyösi M, Repa I, Koller Á, Rőth E, Horváth IG. Evaluation of experimental myocardial infarction models via electromechanical mapping and magnetic resonance imaging. Can J Physiol Pharmacol. 2013;91:617-24.
  • Piechota-Polanczyk A, Demyanets S, Nykonenko O, Huk I, Mittlboeck M, Domenig CM, Neumayer C, Wojta J, Nanobachvili J, Klinger M. Decreased tissue levels of cyclophilin A, a cyclosporine a target and phospho-ERK1/2 in simvastatin patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2013;45:682-8.
  • Richter B, Koller L, Hohensinner PJ, Zorn G, Brekalo M, Berger R, Mörtl D, Maurer G, Pacher R, Huber K, Wojta J, Hülsmann M, Niessner A. A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure. Int J Cardiol. 2013;168:1251-7.
  • Riebandt J, Sandner S, Mahr S, Haberl T, Rajek A, Laufer G, Schima H, Zimpfer D. Minimally invasive thoratec Heartmate II implantation in the setting of severe thoracic aortic calcification. Ann Thorac Surg. 2013;96:1094-6.
  • Saely CH, Rein P, Vonbank A, Huber K, Drexel H. Type 2 diabetes and the progression of visualized atherosclerosis to clinical cardiovascular events. Int J Cardiol. 2013;167:776-80.
  • Siller-Matula JM, Delle-Karth G, Christ G, Neunteufl T, Maurer G, Huber K, Tolios A, Drucker C, Jilma B. Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin. Int J Cardiol. 2013;167:430-5.
  • Rohla M, Freynhofer MK, Tentzeris I, Farhan S, Wojta J, Huber K, Weiss TW. Plasma osmolality predicts clinical outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2014;3:84-92.
  • Testori C, Holzer M, Sterz F, Stratil P, Hartner Z, Moscato F, Schima H, Behringer W. Rapid induction of mild therapeutic hypothermia by extracorporeal veno-venous blood cooling in humans. Resuscitation. 2013;84:1051-5.
  • Zeyda M, Wernly B, Demyanets S, Kaun C, Hämmerle M, Hantusch B, Schranz M, Neuhofer A, Itariu BK, Keck M, Prager G, Wojta J, Stulnig TM. Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. Int J Obes (Lond). 2013;37:658-65.